MCID: BLR004
MIFTS: 37

Biliary Dyskinesia

Categories: Gastrointestinal diseases

Aliases & Classifications for Biliary Dyskinesia

MalaCards integrated aliases for Biliary Dyskinesia:

Name: Biliary Dyskinesia 12 54 43 15 17 71
Sphincter of Oddi Dysfunction 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4140
MeSH 43 D001657
SNOMED-CT 67 43469007
UMLS 71 C0005416

Summaries for Biliary Dyskinesia

Disease Ontology : 12 A gallbladder disease characterized by altered tonus of the sphincter of Oddi, disturbance in the coordination of contraction of the biliary ducts, and/or reduction in the speed of emptying of the biliary tree.

MalaCards based summary : Biliary Dyskinesia, also known as sphincter of oddi dysfunction, is related to bile duct cysts and acalculous cholecystitis. An important gene associated with Biliary Dyskinesia is CCK (Cholecystokinin), and among its related pathways/superpathways are Salivary secretion and Pancreatic secretion. The drugs Pinaverium and Morphine have been mentioned in the context of this disorder. Affiliated tissues include liver, testes and pancreas.

Wikipedia : 74 Biliary dyskinesia is a disorder of some component of biliary part of the digestive system in which bile... more...

Related Diseases for Biliary Dyskinesia

Diseases related to Biliary Dyskinesia via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 199, show less)
# Related Disease Score Top Affiliating Genes
1 bile duct cysts 30.9 PRSS1 GPT
2 acalculous cholecystitis 30.9 GPT CCK
3 cholelithiasis 30.9 SST GPT CCK
4 recurrent acute pancreatitis 30.8 SPINK1 SCT PRSS1 CFTR
5 gastritis 30.5 SST SCT ATP4A
6 postcholecystectomy syndrome 30.5 SOBP CCK
7 duodenal ulcer 30.4 SST SCT CCK
8 cholecystolithiasis 30.4 GPT CCK
9 gastroduodenitis 30.2 ATP4A ATP12A
10 dumping syndrome 30.2 SST SCT CCK
11 choledocholithiasis 30.1 GPT CCK
12 peptic esophagitis 30.1 ATP4A ATP12A
13 hernia, hiatus 30.1 ATP4A ATP12A
14 constipation 30.1 SST CCK ATP4A ATP12A
15 gallbladder disease 30.0 SST GPT CFTR CCK
16 pancreatitis, hereditary 30.0 SPINK1 PRSS1 CFTR
17 peptic ulcer disease 29.8 SST SCT ATP4A ATP12A
18 cholangitis 29.6 SST GPT CFTR
19 duodenogastric reflux 29.6 SST SCT CCK ATP4A ATP12A
20 acute pancreatitis 28.7 SST SPINK1 SCT REG3A PRSS1 GPT
21 pancreatitis 28.2 SST SPINK1 SCT REG3A PRSS1 CFTR
22 cholecystitis 10.6
23 gallbladder disease 1 10.5
24 pancreatic cholera 10.4 SST SCT
25 functionless pituitary adenoma 10.4 SST CCK
26 glucagonoma 10.4 SST SCT
27 tropical calcific pancreatitis 10.4 SPINK1 PRSS1
28 pancreas, annular 10.4 SPINK1 PRSS58
29 dysplastic nevus syndrome 10.3 PRSS58 PRSS1
30 pancreatic vasoactive intestinal peptide producing tumor 10.3 ATP4A ATP12A
31 hemangioma of intra-abdominal structure 10.3 ATP4A ATP12A
32 displacement of cardia through esophageal hiatus 10.3 ATP4A ATP12A
33 acquired gastric outlet stenosis 10.3 ATP4A ATP12A
34 angiodysplasia of intestine 10.3 ATP4A ATP12A
35 benzylpenicillin allergy 10.3 ATP4A ATP12A
36 median arcuate ligament syndrome 10.3 ATP4A ATP12A
37 granulomatous gastritis 10.3 ATP4A ATP12A
38 bacterial esophagitis 10.3 ATP4A ATP12A
39 lingual goiter 10.3 ATP4A ATP12A
40 cascade stomach 10.3 ATP4A ATP12A
41 gastrojejunal ulcer 10.3 ATP4A ATP12A
42 optic papillitis 10.3
43 fungal esophagitis 10.3 ATP4A ATP12A
44 gastric gastrinoma 10.3 ATP4A ATP12A
45 fungal gastritis 10.3 ATP4A ATP12A
46 superior mesenteric artery syndrome 10.3 ATP4A ATP12A
47 pneumatosis cystoides intestinalis 10.3 ATP4A ATP12A
48 dieulafoy lesion 10.3 ATP4A ATP12A
49 esophagus sarcoma 10.3 ATP4A ATP12A
50 esophagus melanoma 10.3 ATP4A ATP12A
51 polyposis, skin pigmentation, alopecia, and fingernail changes 10.3 ATP4A ATP12A
52 necrotizing gastritis 10.3 ATP4A ATP12A
53 central nervous system origin vertigo 10.3 ATP4A ATP12A
54 chronic laryngitis 10.3 ATP4A ATP12A
55 laryngitis 10.3 ATP4A ATP12A
56 cefuroxime allergy 10.3 ATP4A ATP12A
57 chronic intestinal vascular insufficiency 10.3 ATP4A ATP12A
58 peptic ulcer perforation 10.3 ATP4A ATP12A
59 rumination disorder 10.3 ATP4A ATP12A
60 blind loop syndrome 10.3 ATP4A ATP12A
61 crab allergy 10.3 ATP4A ATP12A
62 acute laryngitis 10.3 ATP4A ATP12A
63 gastric dilatation 10.2 ATP4A ATP12A
64 diclofenac allergy 10.2 ATP4A ATP12A
65 internal hemorrhoid 10.2 ATP4A ATP12A
66 hemorrhoid 10.2 ATP4A ATP12A
67 lymphocytic gastritis 10.2 ATP4A ATP12A
68 functional diarrhea 10.2 ATP4A ATP12A
69 gastritis, familial giant hypertrophic 10.2 ATP4A ATP12A
70 eosinophilic gastritis 10.2 ATP4A ATP12A
71 barbiturate abuse 10.2 ATP4A ATP12A
72 aspiration pneumonitis 10.2 ATP4A ATP12A
73 scalp dermatosis 10.2 ATP4A ATP12A
74 cough variant asthma 10.2 ATP4A ATP12A
75 mediastinitis 10.2 ATP4A ATP12A
76 esophageal candidiasis 10.2 ATP4A ATP12A
77 squamous papillomatosis 10.2 ATP4A ATP12A
78 toxic megacolon 10.2 ATP4A ATP12A
79 laryngeal tuberculosis 10.2 ATP4A ATP12A
80 common bile duct disease 10.2 GPT CCK
81 tracheomalacia 10.2 ATP4A ATP12A
82 cardiomyopathy, dilated, 1gg 10.2 ATP4A ATP12A
83 duodenum cancer 10.2 SST SCT
84 viral esophagitis 10.2 ATP4A ATP12A
85 lymphocytic colitis 10.2 ATP4A ATP12A
86 tracheal disease 10.2 ATP4A ATP12A
87 dyskinesia of esophagus 10.2 ATP4A ATP12A
88 myopathy, x-linked, with excessive autophagy 10.2 ATP4A ATP12A
89 pancreatic agenesis 1 10.1 SPINK1 SCT CFTR
90 glossitis 10.1 ATP4A ATP12A
91 duodenal atresia 10.1 SCT CFTR
92 prss1-related hereditary pancreatitis 10.1 SPINK1 PRSS1 CFTR
93 vitamin metabolic disorder 10.1 ATP4A ATP12A
94 biliary tract disease 10.1
95 hypercholesterolemia, familial, 1 10.1
96 paine syndrome 10.1
97 muscle hypertrophy 10.1
98 leptin deficiency or dysfunction 10.1
99 opioid abuse 10.1
100 allergic hypersensitivity disease 10.1
101 somatization disorder 10.1
102 fibromyalgia 10.1
103 adenoma 10.1
104 fascioliasis 10.1
105 47,xyy 10.1
106 chronic pain 10.1
107 dysphagia 10.1
108 swallowing disorders 10.1
109 gastroduodenal crohn's disease 10.1 CCK ATP4A ATP12A
110 bile reflux 10.1 CCK ATP4A ATP12A
111 duodenitis 10.1 CCK ATP4A ATP12A
112 clostridium difficile colitis 10.1 ATP4A ATP12A
113 giardiasis 10.1 SCT ATP4A ATP12A
114 ileus 10.1 SST CFTR CCK
115 primary thrombocytopenia 10.1 ATP4A ATP12A
116 intestinal pseudo-obstruction 10.1 SST PRSS1 CFTR
117 eosinophilic gastroenteritis 10.1 ATP4A ATP12A
118 gastric hemangioma 10.0 SST ATP4A ATP12A
119 esophageal tuberculosis 10.0 SST ATP4A ATP12A
120 pancreas disease 10.0 SST PRSS1 CCK
121 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.0
122 strawberry gallbladder 10.0
123 gastroparesis 10.0
124 esophagitis 10.0
125 gastric antral vascular ectasia 10.0 SST ATP4A ATP12A
126 active peptic ulcer disease 10.0 SST ATP4A ATP12A
127 polycystic liver disease 10.0 SST SCT CFTR
128 pernicious anemia 10.0 SST ATP4A ATP12A
129 microscopic colitis 10.0 ATP4A ATP12A
130 gastric lymphoma 10.0 ATP4A ATP12A
131 autoimmune gastritis 10.0 ATP4A ATP12A
132 protein-energy malnutrition 10.0 GPT CFTR CCK
133 vipoma 10.0 SST SCT
134 neuroendocrine tumor 9.9 SST SCT CCK ATP4A
135 nutritional deficiency disease 9.9 SCT CCK ATP4A ATP12A
136 bile acid malabsorption, primary 9.9 SST SCT CFTR CCK
137 cystic kidney disease 9.9 SST SCT CFTR
138 cervix erosion 9.9 GPT ATP4A ATP12A
139 intestinal volvulus 9.9 GPT ATP4A ATP12A
140 intestinal perforation 9.9 GPT ATP4A ATP12A
141 drug allergy 9.9 GPT ATP4A ATP12A
142 cecal disease 9.9 GPT ATP4A ATP12A
143 aspiration pneumonia 9.9 GPT ATP4A ATP12A
144 vitamin b12 deficiency 9.9 GPT ATP4A ATP12A
145 duodenal obstruction 9.9 SPINK1 PRSS1 ATP4A ATP12A
146 lactose intolerance 9.9 ATP4A ATP12A
147 exanthem 9.9 GPT ATP4A ATP12A
148 gastroesophageal reflux 9.9
149 breast cancer 9.9
150 hypertriglyceridemia, familial 9.9
151 migraine with or without aura 1 9.9
152 polyposis, gastric 9.9
153 dermatitis, atopic 9.9
154 body mass index quantitative trait locus 1 9.9
155 inflammatory bowel disease 9.9
156 gastric ulcer 9.9
157 heart disease 9.9
158 goiter 9.9
159 hepatitis a 9.9
160 nontoxic goiter 9.9
161 cholestasis 9.9
162 ascending cholangitis 9.9
163 echinococcosis 9.9
164 urticaria 9.9
165 viral hepatitis 9.9
166 hepatitis 9.9
167 dermatitis 9.9
168 causalgia 9.9
169 bladder disease 9.9
170 neurotic disorder 9.9
171 bronchitis 9.9
172 atrophic gastritis 9.9
173 achalasia 9.9
174 irritable bowel syndrome 9.9
175 carotenemia 9.9
176 48,xyyy 9.9
177 hypotonia 9.9
178 autoimmune disease of gastrointestinal tract 9.9 GPT ATP4A ATP12A
179 duodenal gastrinoma 9.9 SST SCT ATP4A ATP12A
180 pancreatic steatorrhea 9.9 SCT PRSS1 CELA1 CCK
181 pancreatic gastrinoma 9.9 SST SCT ATP4A ATP12A
182 angiodysplasia 9.9 SST SCT ATP4A ATP12A
183 duodenum disease 9.9 SST SCT ATP4A ATP12A
184 zollinger-ellison syndrome 9.9 SST SCT ATP4A ATP12A
185 portal hypertension 9.8 SST GPT CFTR
186 multiple endocrine neoplasia, type i 9.8 SST SCT ATP4A ATP12A
187 esophageal varix 9.7 SST GPT ATP4A ATP12A
188 secretory diarrhea 9.7 SST CFTR
189 hepatic vascular disease 9.7 SST GPT ATP4A ATP12A
190 vein disease 9.6 SST GPT ATP4A ATP12A
191 diarrhea 9.5 SST SCT GPT CFTR CCK
192 exocrine pancreatic insufficiency 9.5 SPINK1 SCT CFTR CELA1 CCK
193 pancreatic adenocarcinoma 9.5 SST SPINK1 SCT PRSS1 CFTR CCK
194 functional gastric disease 9.5 SST GPT CCK ATP4A ATP12A
195 celiac disease 1 9.5 SCT CELA1 CCK ATP4A ATP12A
196 cystic fibrosis 9.3 SPINK1 REG3A PRSS1 CFTR
197 intestinal obstruction 9.3 SST GPT CFTR ATP4A ATP12A
198 alcoholic pancreatitis 9.1 SPINK1 SCT REG3A PRSS1 CFTR CCK
199 pancreatic cancer 8.8 SST SPINK1 SCT REG3A PRSS1 CFTR

Graphical network of the top 20 diseases related to Biliary Dyskinesia:



Diseases related to Biliary Dyskinesia

Symptoms & Phenotypes for Biliary Dyskinesia

Drugs & Therapeutics for Biliary Dyskinesia

Drugs for Biliary Dyskinesia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 52, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Pinaverium Approved Phase 4 59995-65-2
2
Morphine Approved, Investigational Phase 4 57-27-2 5288826
3
Neostigmine Approved, Vet_approved Phase 4 59-99-4 4456
4
Secretin Approved Phase 4 108153-74-8
5 Anticonvulsants Phase 4
6 Parasympatholytics Phase 4
7 calcium channel blockers Phase 4
8 Bromides Phase 4
9 Hormones Phase 4
10 Autonomic Agents Phase 4
11 Neurotransmitter Agents Phase 4
12 Analgesics Phase 4
13 Gastrointestinal Agents Phase 4
14 Narcotics Phase 4
15 Hormone Antagonists Phase 4
16 Analgesics, Opioid Phase 4
17 Cholinergic Agents Phase 4
18 Cholinesterase Inhibitors Phase 4
19
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
20
Norepinephrine Approved Phase 3 51-41-2 439260
21
Indomethacin Approved, Investigational Phase 3 53-86-1 3715
22
Calcium Approved, Nutraceutical Phase 3 7440-70-2 271
23
Emodepside Investigational, Vet_approved Phase 3 155030-63-0
24 Calcium, Dietary Phase 3
25 Dopamine Agents Phase 3
26 Psychotropic Drugs Phase 3
27 Serotonin and Noradrenaline Reuptake Inhibitors Phase 3
28 Antidepressive Agents Phase 3
29 Duloxetine Hydrochloride Phase 3
30 Analgesics, Non-Narcotic Phase 3
31 Anti-Inflammatory Agents, Non-Steroidal Phase 3
32 Antirheumatic Agents Phase 3
33 Cyclooxygenase Inhibitors Phase 3
34 Anti-Inflammatory Agents Phase 3
35 Tocolytic Agents Phase 3
36 Pharmaceutical Solutions Phase 3
37
Serotonin Investigational, Nutraceutical Phase 3 50-67-9 5202
38
Perphenazine Approved Phase 2 58-39-9 4748
39
Amitriptyline Approved Phase 2 50-48-6 2160
40 Antipsychotic Agents Phase 2
41 Tranquilizing Agents Phase 2
42 Amitriptyline, perphenazine drug combination Phase 2
43 Antidepressive Agents, Tricyclic Phase 2
44 Adrenergic Agents Phase 2
45
Pancrelipase Approved, Investigational Phase 1 53608-75-6
46 pancreatin Phase 1
47
Diclofenac Approved, Vet_approved 15307-86-5 3033
48
Ropivacaine Approved 84057-95-4 71273 175805
49
Bupivacaine Approved, Investigational 2180-92-9, 38396-39-3 2474
50 Central Nervous System Depressants
51 Anesthetics, Local
52 Anesthetics

Interventional clinical trials:

(showing 25, show less)
# Name Status NCT ID Phase Drugs
1 Application of Pinaverium Bromide in the Treatment of Patients With Post-cholecystectomy Sphincter of Oddi Dysfunction (SOD): A Randomized, Controlled and Multicenter Clinical Study Unknown status NCT02833103 Phase 4 Danshu Capsules;Pinaverium Bromide
2 A Randomised, Double Blind Cross-over Study of Serial MRCP Following Morphine-neostigmine and Secretin Provocation in Healthy Volunteers Completed NCT01134848 Phase 4 Morphine;Neostigmine;0.9% saline;Secretin;0.9% saline
3 A Prospective Randomised Trial of 0.025 Wire Guided Cannulation Versus Current Practice 0.035 Wire Guided Cannulation Completed NCT01408264 Phase 4
4 Pilot Study of the Efficacy and Tolerability of Duloxetine in Patients With Suspected Functional Pancreatic/Biliary Pain (Sphincter of Oddi Dysfunction). Completed NCT00471315 Phase 3 Duloxetine
5 Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) - Induced Pancreatitis Using Aggressive Lactated Ringer's Infusion and/or Rectal Indomethacin Completed NCT02641561 Phase 3 Indomethacin;Lactated Ringer's Solution;Normal Saline;Placebo
6 Randomized Controlled Trial of Laparoscopic Cholecystectomy vs. Non-operative Treatment for Gallbladder Dyskinesia Unknown status NCT02195115 Phase 2 amitriptyline
7 Prospective Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis Not yet recruiting NCT03977779 Phase 2
8 The Use of Non-invasive MRI to Quantify the Effect of Secretin on Pancreatic Blood Flow and Perfusion in Healthy Volunteers Completed NCT01452217 Phase 1 Secretin
9 Laparoscopic Cholecystectomy Using Transvaginal Endoscopic Assistance Withdrawn NCT00815438 Phase 1
10 Intramuscular Diclofenac in the Prevention of Post-ERCP Pancreatitis Unknown status NCT01717599 Diclofenac;normal saline
11 A Phase III Randomized Multicenter Clinical Trial of Sphincterotomy for the Treatment of SOD III Patients Completed NCT00688662
12 Early Precut Versus Pancreatic Duct Stent in Preventing Post-ERCP Pancreatitis in High-risk Subjects Completed NCT02497872
13 Effect of Anatomy of Major Duodenal Papilla on the Difficulty of Cannulation During Endoscopic Retrograde Cholangiopancreatography (ERCP) Completed NCT03550768
14 Defining the Role of ERCP in the Evaluation and Treatment of Idiopathic Recurrent Acute Pancreatitis Completed NCT01583517
15 Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method in Patients With High Risk of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Multicenter Randomized Controlled Trial Completed NCT02916199
16 Single Incision Versus Laparoscopic Cholecystectomy Completed NCT00981604
17 A Prospective, Multicenter, Randomized, Double-blind Controlled Study to Determine Whether a Single Dose of Intraduodenal Indomethacin Can Decrease the Incidence and Severity of Post-ERCP Pancreatitis Completed NCT00727740 Indomethacin;Placebo suspension
18 Natural Orifice Translumenal Endoscopic Surgery (NOTES) Transvaginal Cholecystectomy Completed NCT00984100
19 A Prospective Pilot Study to Evaluate the Effect of Virtual Reality as a Treatment Option for Pain in Patients With Functional Pancreaticobiliary Disorder or Type 3 Sphincter of Oddi Dysfunction Recruiting NCT03999333
20 QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing Recruiting NCT03434392
21 COMPLICATIONS OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY- AN INDIAN PERSPECTIVE Active, not recruiting NCT04062617
22 Trans-incisional Rectus Sheath Block Versus Laparoscopic Guided Rectus Sheath Block for Pediatric Single Incision Laparoscopic Cholecystectomy: A Prospective, Randomized Study Active, not recruiting NCT02494336 Ropivacaine
23 Evaluation of Gastrointestinal Symptoms and Quality of Life in Patients With Sphincter of Oddi Dysfunction: Evaluation of the Differences Between Those Undergoing Endoscopic Therapy vs.Conservative Care Terminated NCT01410071
24 Study to Investigate the Role of Ultrasound for Diagnosis of Biliary Dyskinesia Terminated NCT00737295
25 Single-Incision Laparoscopic Cholecystectomy Versus Traditional Laparoscopic Cholecystectomy: A Randomized Prospective Trial Terminated NCT01195285

Search NIH Clinical Center for Biliary Dyskinesia

Cochrane evidence based reviews: biliary dyskinesia

Genetic Tests for Biliary Dyskinesia

Anatomical Context for Biliary Dyskinesia

MalaCards organs/tissues related to Biliary Dyskinesia:

40
Liver, Testes, Pancreas, Spinal Cord, Colon, Bone, Heart

Publications for Biliary Dyskinesia

Articles related to Biliary Dyskinesia:

(showing 972, show less)
# Title Authors PMID Year
1
Biliary dyskinesia: a potentially unrecognized cause of abdominal pain in children. 54 61
15322841 2004
2
Laparoscopic cholecystectomy for biliary dyskinesia: correlation of preoperative cholecystokinin cholescintigraphy results with postoperative outcome. 54 61
15054652 2004
3
Biliary dyskinesia: role of the sphincter of Oddi, gallbladder and cholecystokinin. 61 54
9374365 1997
4
Abnormal gallbladder nuclear ejection fraction predicts success of cholecystectomy in patients with biliary dyskinesia. 54 61
8273847 1993
5
Kinevac (sincalide for injection)/Squibb Diagnostics. 61 54
1932168 1991
6
Self-reported Outcomes After Cholecystectomy for Pediatric Hyperkinetic Biliary Dyskinesia. 61
31562988 2020
7
Functional Pancreatic Sphincter Dysfunction in Children: Recommendations for Diagnosis and Management. 61
31567892 2019
8
Risk factors of post-ERCP pancreatitis in high-risk patients despite prevention with prophylactic pancreatic stents. 61
31852319 2019
9
Maintaining the blind in sham controlled interventional trials: lessons from the EPISOD study. 61
31673601 2019
10
Overall outcomes of laparoscopic-assisted ERCP after Roux-en-Y gastric bypass and sphincter of Oddi dysfunction subgroup analysis. 61
31579709 2019
11
Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment. 61
31413535 2019
12
Clinical features and management of painless biliary type sphincter of Oddi dysfunction. 61
31122105 2019
13
Sphincter of Oddi Dysfunction After Gastric Bypass: Surgical or Endoscopic Therapy? 61
30738357 2019
14
Effects of Paeoniflorin on the activity of muscle strips, intracellular calcium ion concentration and L‑type voltage‑sensitive calcium ion channels in the sphincter of Oddi of hypercholesterolemic rabbits. 61
31059080 2019
15
Variability in perioperative evaluation and resource utilization in pediatric patients with suspected biliary dyskinesia: A multi-institutional retrospective cohort study. 61
30885555 2019
16
Biliary Tract Disease in Girls and Young Women With Rett Syndrome. 61
30664568 2019
17
Surgical outcome in patients with biliary colic and atypical workup findings. 61
31000093 2019
18
Is hyperkinetic gallbladder an indication for cholecystectomy? 61
30209609 2019
19
Laparoscopic cholecystectomy for ultrasound normal gallbladders: Should we forego hepatobiliary iminodiacetic acid scans? 61
30924462 2019
20
An Update on Biliary Dyskinesia. 61
30846030 2019
21
Systematic review with meta-analysis: cholecystectomy for biliary dyskinesia-what can the gallbladder ejection fraction tell us? 61
30706496 2019
22
A systematic review of the aetiology and management of post cholecystectomy syndrome. 61
29730174 2019
23
Role of laparoscopic cholecystectomy in the management of chronic right upper quadrant pain due to biliary dyskinesia: a systematic review and meta-analysis. 61
31620653 2019
24
Biliary hyperkinesia, a new diagnosis or misunderstood pathophysiology of dyskinesia: A case report. 61
30716707 2019
25
Clinical course of biliary-type sphincter of Oddi dysfunction: endoscopic sphincterotomy and functional dyspepsia as affecting factors. 61
31448369 2019
26
Characterization of the urinary metabolic profile of cholangiocarcinoma in a United Kingdom population. 61
31118840 2019
27
Etiologies of Long-Term Postcholecystectomy Symptoms: A Systematic Review. 61
31110517 2019
28
Recurrent Acute Pancreatitis: Current Concepts in the Diagnosis and Management. 61
30232693 2018
29
Update on the Prevention of Post-ERCP Pancreatitis. 61
30334143 2018
30
Biliary endoscopic sphincterotomy: Techniques and complications. 61
30613665 2018
31
Risk Factors for Post-ERCP Pancreatitis in High-Risk Patients Receiving Post-procedure Rectal Indomethacin. 61
29980976 2018
32
Long-term results of cholecystectomy for biliary dyskinesia: outcomes and resource utilization. 61
30100038 2018
33
Acute Biliary Disease. 61
30243451 2018
34
Pediatric Biliary Dyskinesia: Evaluating Predictive Factors for Successful Treatment of Biliary Dyskinesia with Laparoscopic Cholecystectomy. 61
30268165 2018
35
Sphincter of Oddi dysfunction: sphincter of Oddi dysfunction or discordance? What is the state of the art in 2018? 61
29916850 2018
36
Adverse Events and Reinterventions Following Pancreatic Endoscopic Sphincterotomy. 61
29912853 2018
37
Post-ERCP biliary complications in patients with biliary type sphincter of Oddi dysfunction. 61
29967373 2018
38
Pathologic Findings of the Gallbladder in Patients Undergoing Surgery for Biliary Dyskinesia 61
29981584 2018
39
Rectal Indomethacin Prevents Moderate to Severe Post-ERCP Pancreatitis and Death and Should Be Used Before the Procedure: A Meta-Analysis of Aggregate Subgroup Data. 61
31294402 2018
40
Trends of Cholecystectomies for Presumed Biliary Dyskinesia in Children in the United States. 61
29036007 2018
41
Idiopathic Pancreatitis as a Rare Gastrointestinal Manifestation of Myotonic Muscular Dystrophy. 61
29805942 2018
42
Cost Effective Therapy for Sphincter of Oddi Dysfunction. 61
28711688 2018
43
Poor Reproducibility of Gallbladder Ejection Fraction by Biliary Scintigraphy for Diagnosis of Biliary Dyskinesia. 61
29157795 2018
44
Effects of laparoscopic cholecystectomy in normokinetic biliary dyskinesia. 61
28669533 2018
45
Sphincter of Oddi dysfunction: the never-ending story has come to a conclusion. 61
29241851 2018
46
The EPISOD study: long-term outcomes. 61
28455162 2018
47
Randomized sham-controlled trials in endoscopy: a systematic review and meta-analysis of adverse events. 61
28802556 2017
48
Biliary Complications in Recipients of Living-Donor Liver Transplant: A Single-Center Review of 120 Patients. 61
29025382 2017
49
Influence of discharge timing and diagnosis on outcomes of pediatric laparoscopic cholecystectomy. 61
29050888 2017
50
Diabetes and the Pancreatobiliary Diseases. 61
29079901 2017
51
Gallbladder Dysfunction: Cholecystitis, Choledocholithiasis, Cholangitis, and Biliary Dyskinesia. 61
29132521 2017
52
Endoscopic retrograde cholangiopancreatography with ampullary biopsy vs ERCP alone: a matched-pairs controlled evaluation of outcomes and complications. 61
28065885 2017
53
Eluxadoline in irritable bowel syndrome with diarrhea: rationale, evidence and place in therapy. 61
29090081 2017
54
Variation in prophylactic antibiotic use for laparoscopic cholecystectomy: need for better stewardship in pediatric surgery. 61
29106917 2017
55
Risk factors of pancreatitis after endoscopic sphincterotomy. Review of literature and practical remarks based on approximately 10,000 ERCPs. 61
29154236 2017
56
Risk factors of post- endoscopic retrograde cholangiopancreatography pancreatitis in biliary type sphincter of Oddi dysfunction in Japanese patients. 61
28898571 2017
57
Outcomes of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Sphincterotomy for Suspected Sphincter of Oddi Dysfunction (SOD) Post Roux-En-Y Gastric Bypass. 61
28488091 2017
58
Outcomes of Laparoscopic Cholecystectomy for Biliary Dyskinesia in Children. 61
28350202 2017
59
Prophylaxis of pancreatitis with intravenous ketoprofen in a consecutive population of ERCP patients: a randomized double-blind placebo-controlled trial. 61
27651353 2017
60
Decision-making patterns in managing children with suspected biliary dyskinesia. 61
28540197 2017
61
Nineteen-year trends in incidence and indications for laparoscopic cholecystectomy: the NY State experience. 61
27604366 2017
62
Gall Bladder Agenesis: A Rare Embryonic Cause of Recurrent Biliary Colic. 61
28365715 2017
63
Analysis of the risk factors for severity in post endoscopic retrograde cholangiopancreatography pancreatitis: The indication of prophylactic treatments. 61
28465786 2017
64
Two-Incision Laparoscopic Cholecystectomy in Children. 61
28085557 2017
65
Obesity Increases Operative Time in Children Undergoing Laparoscopic Cholecystectomy. 61
27875102 2017
66
Eluxadoline-Associated Pancreatitis in a Post-Cholecystectomy Patient: A Case Report. 61
29894043 2017
67
Biliary Dyskinesia in Children: A Systematic Review. 61
27472474 2017
68
Chronic cholecystitis in the pediatric population: an underappreciated disease process. 61
28702136 2017
69
Liver Function Assessment by Magnetic Resonance Imaging. 61
27986173 2016
70
Post-cholecystectomy syndrome and sphincter of Oddi dysfunction: past, present and future. 61
27762149 2016
71
[Recurrent pancreatitis secondary to sphincter of Oddi dysfunction: case report]. 61
27813508 2016
72
Role of ERCP in Patients With Idiopathic Recurrent Acute Pancreatitis. 61
27371265 2016
73
Novel findings in the management of acute pancreatitis. 61
27888858 2016
74
Sphincter of Oddi Dysfunction: A Perplexing Presentation. 61
28100991 2016
75
Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study. 61
27165434 2016
76
Management of Sphincter of Oddi Dysfunction: Teaching an Old SOD New Tricks? 61
27435328 2016
77
Wide disparities in attitudes and practices regarding Type II sphincter of Oddi dysfunction: a survey of expert U.S. endoscopists. 61
27652298 2016
78
Early precut is as efficient as pancreatic stent in preventing post-ERCP pancreatitis in high-risk subjects - A randomized study. 61
27604474 2016
79
Prospective Endoscopic Ultrasound-Based Approach to the Evaluation of Idiopathic Pancreatitis: Causes, Response to Therapy, and Long-term Outcome. 61
27325219 2016
80
Cystoisospora belli Infection of the Gallbladder in Immunocompetent Patients: A Clinicopathologic Review of 18 Cases. 61
27158759 2016
81
Gallbladder disease in children. 61
27521713 2016
82
Nosocomial Staphylococcal Toxic Shock. Case Report. 61
29967853 2016
83
Gallbladder Ejection Fraction Is Unrelated to Gallbladder Pathology in Children and Adolescents. 61
26670710 2016
84
Opium-related sphincter of Oddi dysfunction causing double duct sign. 61
27503161 2016
85
Papillary cannulation and sphincterotomy techniques at ERCP: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. 61
27299638 2016
86
The Utility of Nuclear Medicine Scans for Diagnosing Pediatric Biliary Dyskinesia Remains Unclear. 61
27149253 2016
87
Sphincter of Oddi Manometry: Reproducibility of Measurements and Effect of Sphincterotomy in the EPISOD Study. 61
26951046 2016
88
A multicenter study of initial experience with single-incision robotic cholecystectomies (SIRC) demonstrating a high success rate in 465 cases. 61
26541728 2016
89
Innervation of Extrahepatic Biliary Tract, With Special Reference to the Direct Bidirectional Neural Connections of the Gall Bladder, Sphincter of Oddi and Duodenum in Suncus murinus, in Whole-Mount Immunohistochemical Study. 61
26179953 2016
90
Pilot Randomized Controlled Trial of Laparoscopic Cholecystectomy vs Active Nonoperative Therapy for the Treatment of Biliary Dyskinesia. 61
27049778 2016
91
Safety of outpatient laparoscopic cholecystectomy in children: analysis of 2050 elective ACS NSQIP-pediatric cases. 61
27037702 2016
92
Biliary Complications After Liver Transplantation: Incidence, Risk Factors and Impact on Patient and Graft Survival. 61
27110025 2016
93
Implications of gallbladder cholesterolosis and cholesterol polyps? 61
26409755 2016
94
Rome IV. Gallbladder and Sphincter of Oddi Disorders. 61
27144629 2016
95
Translational and clinical perspectives on sphincter of Oddi dysfunction. 61
27555792 2016
96
Therapeutic Endoscopy Can Be Performed Safely in an Ambulatory Surgical Center: A Multicenter, Prospective Study. 61
27840569 2016
97
[DIFFERENTIAL MANAGEMENT AT THE SPHINCTER OF ODDI DYSFUNCTION AFTER CHOLECYSTECTOMY]. 61
30284426 2016
98
Robotic Single- and Multisite Cholecystectomy in Children. 61
26580829 2015
99
[Diagnosis of sphincter of Oddi dysfunction in patients with postcholecystectomy syndrome from hepatobiliary scintigraphic findings]. 61
26999929 2015
100
Sphincter of Oddi Dysfunction and the Formation of Adult Choledochal Cyst Following Cholecystectomy: A Retrospective Cohort Study. 61
26632721 2015
101
In response to: Preston JF, Diggs BS, Dolan JP, Gilbert EW, Schein M, Hunter JG. Biliary dyskinesia: a surgical disease rarely found outside the United States. Am J Surg. 2015;209:799-803. 61
26116320 2015
102
Erratum to: A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction. 61
26438337 2015
103
Sphincter of Oddi Dysfunction. 61
26431602 2015
104
Prediction of symptom improvement in children with biliary dyskinesia. 61
25891671 2015
105
Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled study. 61
26165739 2015
106
Sphincter of Oddi Dysfunction: Updates from the Recent Literature. 61
26143628 2015
107
Success of single-balloon enteroscopy in patients with surgically altered anatomy. 61
25841583 2015
108
A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction. 61
25868629 2015
109
Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Meta-analysis. 61
26168316 2015
110
Risk factors for post-ERCP pancreatitis: A systematic review and meta-analysis. 61
25547802 2015
111
Complications of laparoscopic transgastric ERCP in patients with Roux-en-Y gastric bypass. 61
25318366 2015
112
Suprahepatic Gallbladder. 61
25761535 2015
113
Cholesterol lowering effect in the gall bladder of dogs by a standardized infusion of Herniaria hirsuta L. 61
25862963 2015
114
HIDA Scan with Ejection Fraction Is over Utilized in the Management of Biliary Dyskinesia. 61
26140885 2015
115
Chronic cholecystitis with Cystoisospora belli in an immunocompetent patient. 61
26065551 2015
116
Same day discharge after laparoscopic cholecystectomy in children. 61
25770737 2015
117
Biliary dyskinesia: a surgical disease rarely found outside the United States. 61
25771131 2015
118
Sphincter of Oddi dysfunction Type III: New studies suggest new approaches are needed. 61
26019439 2015
119
Precut sphincterotomy: efficacy for ductal access and the risk of adverse events. 61
25440676 2015
120
Determinants of long-term complications of endoscopic sphincterotomy are infections and high risk factors of bile duct and not sphincter of Oddi dysfunction. 61
25874514 2015
121
Rotational assisted endoscopic retrograde cholangiopancreatography in patients with reconstructive gastrointestinal surgical anatomy. 61
25789100 2015
122
Hepatectomy with primary closure of common bile duct for hepatolithiasis combined with choledocholithiasis. 61
25834321 2015
123
Post-endoscopic retrograde cholangiopancreatography pancreatitis. 61
25406464 2015
124
ERCP-related perforations in the new millennium: A large tertiary referral center 10-year experience. 61
25653856 2015
125
Endoscopic sphincterotomy for sphincter of oddi dysfunction: inefficacious therapy for a fictitious disease. 61
25532810 2015
126
Spinal cord stimulation for intractable visceral pain due to sphincter of oddi dysfunction. 61
25589948 2015
127
Endoscopic or laparoscopic approach for hepatolithiasis in the era of endoscopy in China. 61
25027471 2015
128
[THE GEPATOPANCREATOBILIARY SYSTEM AFTER CHOLECYSTECTOMY]. 61
26931006 2015
129
CT severity of post-ERCP pancreatitis: results from a single tertiary medical center. 61
24770607 2014
130
Acute recurrent pancreatitis: Etiopathogenesis, diagnosis and treatment. 61
25493002 2014
131
Predictive factors for post-ERCP pancreatitis: a large-scale single expertized endoscopist study. 61
24732733 2014
132
Cholecystectomy for biliary dyskinesia: how did we get there? 61
25193389 2014
133
Cholecystectomy for biliary dyskinesia in gastroparesis: mimic or misfortune? 61
25502153 2014
134
Hepatobiliary scintigraphy in 2014. 61
25472513 2014
135
Commentary on "Cholecystectomy for biliary dyskinesia in gastroparesis: mimic or misfortune?". 61
25502154 2014
136
[Imbalance of microelements and vitamins in adolescents with diffuse nontoxic goiter and biliary dyskinesia]. 61
25528853 2014
137
Black bile of melancholy or gallstones of biliary colics: historical perspectives on cholelithiasis. 61
25102982 2014
138
IgG4 Levels in Bile for Distinguishing IgG4-Associated Cholangiopathy from Other Biliary Disorders: A Single Blinded Pilot Study. 61
25505722 2014
139
Pain provocation and low gallbladder ejection fraction with CCK cholescintigraphy are not predictive of chronic acalculous gallbladder disease symptom relief after cholecystectomy. 61
24852884 2014
140
Classification schema of symptomatic enterogastric reflux utilizing sincalide augmentation on hepatobiliary scintigraphy. 61
25033884 2014
141
[Endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction after cholecystectomy: the last EPISOD]. 61
25362766 2014
142
Postoperative biliary adverse events following orthotopic liver transplantation: assessment with magnetic resonance cholangiography. 61
25170197 2014
143
Recent research on sphincter of oddi dysfunction. 61
25904832 2014
144
Hepatobiliary scintigraphy in 2014. 61
24744445 2014
145
Lipidomic profiling of bile in distinguishing benign from malignant biliary strictures: a single-blinded pilot study. 61
24710507 2014
146
Twenty years of surveillance in Rett syndrome: what does this tell us? 61
24942262 2014
147
Biliary dyskinesia and symptomatic gallstone disease in children: two sides of the same coin? 61
24715545 2014
148
Choledocholithiasis diagnostics - endoscopic ultrasound or endoscopic retrograde cholangiopancreatography? 61
26672977 2014
149
Adult bile duct strictures: role of MR imaging and MR cholangiopancreatography in characterization. 61
24819781 2014
150
Can patient and pain characteristics predict manometric sphincter of Oddi dysfunction in patients with clinically suspected sphincter of Oddi dysfunction? 61
24472759 2014
151
Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years. 61
24886445 2014
152
Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial. 61
24867013 2014
153
UK wide survey on the prevention of post-ERCP pancreatitis. 61
24724007 2014
154
Anatomy and embryology of the biliary tract. 61
24679417 2014
155
Risk factors associated with the development of hyperamylasemia and post-ERCP pancreatitis in the Cuban National Institute. 61
25028902 2014
156
Biliary dyskinesia in pediatrics. 61
24716563 2014
157
Long-term efficacy of laparoscopic cholecystectomy for the treatment of biliary dyskinesia. 61
24581761 2014
158
Psychosocial characteristics and pain burden of patients with suspected sphincter of Oddi dysfunction in the EPISOD multicenter trial. 61
24445573 2014
159
Osteopathic manipulative treatment in the management of biliary dyskinesia. 61
24481806 2014
160
Prevention of post-ERCP pancreatitis. 61
24891970 2014
161
Increased fat in pancreas not associated with risk of pancreatitis post-endoscopic retrograde cholangiopancreatography. 61
24959090 2014
162
Impact of pancreatic stent caliber on post-endoscopic retrograde cholangiopancreatogram pancreatitis rates in patients with confirmed sphincter of Oddi dysfunction. 61
24617703 2014
163
EPISOD puts an end to sphincter of Oddi dysfunction type III. 61
25330818 2014
164
Gallbladder dysfunction: how much longer will it be controversial? 61
25278145 2014
165
Acalculous cholecystitis or biliary dyskinesia for Epstein-Barr virus gallbladder involvement? 61
24874936 2014
166
Intraoperative management of a carbon dioxide embolus in the setting of laparoscopic cholecystectomy for a patient with primary biliary cirrhosis: A case report. 61
25462045 2014
167
[Condition of neurohumoral regulation of bronchial tone and gallbladder in patients with chronic cholecystitis and chronic obstructive pulmonary disease]. 61
25796858 2014
168
Risk factors for therapeutic ERCP-related complications: an analysis of 2,715 cases performed by a single endoscopist. 61
24714755 2014
169
Clinical significance of the UGT1A1*28 allele detection in HIV-infected patients. 61
25394086 2014
170
Defining a therapeutic program for recurrent acute pancreatitis patients with unknown etiology. 61
24833943 2014
171
Multi-institutional analysis of long-term symptom resolution after cholecystectomy for biliary dyskinesia in children. 61
23846453 2013
172
Contemporary experience with cholecystectomy: establishing 'benchmarks' two decades after the introduction of laparoscopic cholecystectomy. 61
24351351 2013
173
Self-administered electroacupuncture provides symptomatic relief in a patient with sphincter of Oddi dysfunction: a patient's report. 61
24008012 2013
174
Sphincter of Oddi dysfunction: an evidence-based review. 61
24161134 2013
175
Pancreato-biliary Endoscopic Ultrasound in Opium Addicts Presenting with Abdominal Pain. 61
24949397 2013
176
Sphincter of Oddi manometry using guide-wire-type manometer is feasible for examination of sphincter of Oddi motility. 61
23179609 2013
177
Diagnostic stringency and healthcare needs in patients with biliary dyskinesia. 61
23934412 2013
178
Etiology and incidence of pediatric gallbladder disease. 61
24074432 2013
179
Laparoscopic cholecystectomy for biliary dyskinesia: Which patients have long term benefit? 61
24074413 2013
180
Emphysematous Cholecystitis Resulting in Secondary Biliary Cirrhosis: A Rare Complication of Endoscopic Retrograde Cholangiopancreatography. 61
26157820 2013
181
Patient perception of single-incision laparoscopic cholecystectomy. 61
24398201 2013
182
Current Concepts and Controversies in Foregut Motility: the 2012 Kelly and Carlos Pellegrini SSAT/SAGES Joint Symposium. 61
23801520 2013
183
Biliary dyskinesia: does it exist? If so, how do we diagnose it? Is laparoscopic cholecystectomy effective or a sham operation? 61
23818126 2013
184
Sphincter of Oddi dysfunction: how is it diagnosed? How is it classified? How do we treat it medically, endoscopically, and surgically? 61
23860677 2013
185
Single-session ERCP in patients with previous Roux-en-Y gastric bypass using percutaneous-assisted transprosthetic endoscopic therapy: a case series. 61
23881807 2013
186
ERCP via gastrostomy vs. double balloon enteroscopy in patients with prior bariatric Roux-en-Y gastric bypass surgery. 61
23793801 2013
187
Laparoscopic cholecystectomy for biliary dyskinesia in children: frequency increasing. 61
23932611 2013
188
Association between cholecystectomy with vs without intraoperative cholangiography and risk of common duct injury. 61
23982367 2013
189
Risk models for post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP): smoking and chronic liver disease are predictors of protection against PEP. 61
23532001 2013
190
Early measures of hemoconcentration and inflammation are predictive of prolonged hospitalization from post- endoscopic retrograde cholangiopancreatography pancreatitis. 61
23648842 2013
191
Recurrent acute pancreatitis: an approach to diagnosis and management. 61
24851521 2013
192
Regional differences in hospitalizations and cholecystectomies for biliary dyskinesia. 61
23875106 2013
193
Single-incision laparoscopic cholecystectomy is associated with improved cosmesis scoring at the cost of significantly higher hernia rates: 1-year results of a prospective randomized, multicenter, single-blinded trial of traditional multiport laparoscopic cholecystectomy vs single-incision laparoscopic cholecystectomy. 61
23619321 2013
194
Broad clinical utilization of NOTES: is it safe? 61
23479251 2013
195
[Diagnosis and management for the non-traumatic epidural sequestered cervical disc extrusion]. 61
24015651 2013
196
The underestimated role of opiates in sphincter of Oddi dysfunction. 61
23628270 2013
197
A laparoscopic transgastric approach to the treatment of sphincter of Oddi dysfunction postgastric bypass. 61
23704421 2013
198
Commentary on "Risk Stratification for the Development of Post-ERCP Pancreatitis by Sphincter of Oddi Dysfunction Classification". 61
23644637 2013
199
Biliary complications following liver transplantation. 61
23704818 2013
200
Laparo-endoscopic single-site (LESS) cholecystectomy with epidural vs. general anesthesia. 61
23242490 2013
201
Risk stratification for the development of post-ERCP pancreatitis by sphincter of Oddi dysfunction classification. 61
23644636 2013
202
Functional MR cholangiography of the cystic duct and sphincter of Oddi using gadoxetate disodium: is a 30-minute delay long enough? 61
23001618 2013
203
Preoperative symptom duration predicts success in relieving abdominal pain caused by biliary dyskinesia in a pediatric population. 61
23583136 2013
204
Single-incision laparoscopic cholecystectomy for biliary dyskinesia in children: a simple, safe, and inexpensive technique. 61
23573884 2013
205
Single-incision laparoscopic cholecystectomy (SILC) using non-articulating instruments and conventional trocars-single surgeon experience. 61
23188225 2013
206
How do we manage post-OLT redundant bile duct? 61
23674851 2013
207
Endoscopic approach to the patient with motility disorders of the bile duct and sphincter of Oddi. 61
23540967 2013
208
Utility of the short double-balloon enteroscope to perform pancreaticobiliary interventions in patients with surgically altered anatomy in a US multicenter study. 61
22975796 2013
209
Prospective evaluation of single-operator peroral cholangioscopy in liver transplant recipients requiring an evaluation of the biliary tract. 61
23404861 2013
210
[The effect of endoscopic sphincterotomy on the motility of the gallbladder and of the sphincter of Oddi in patients with acalculous biliary pain syndrome]. 61
23419531 2013
211
Commentary: the rising tide of cholecystectomy for biliary dyskinesia - author's reply. 61
23336682 2013
212
Commentary: the rising tide of cholecystectomy for biliary dyskinesia. 61
23336681 2013
213
The rising tide of cholecystectomy for biliary dyskinesia. 61
23106129 2013
214
[Prevalence and risk factors of gastroduodenal and biliary system diseases in infants and preschool children]. 61
24933954 2013
215
Therapeutic roles of curcumin: lessons learned from clinical trials. 61
23143785 2013
216
[Mebeverina drugs in the treatment of functional disorders of the digestive system]. 61
24501945 2013
217
Biliary cast syndrome in an opium inhaler. 61
24163648 2013
218
Endoscopic therapy for sphincter of Oddi dysfunction in idiopathic pancreatitis: from empiric to scientific. 61
23089546 2012
219
Periampullary diverticulum may be an important factor for the occurrence and recurrence of bile duct stones. 61
22911215 2012
220
Single-incision surgery has higher cost with equivalent pain and quality-of-life scores compared with multiple-incision laparoscopic cholecystectomy: a prospective randomized blinded comparison. 61
22819642 2012
221
Normokinetic biliary dyskinesia: a novel diagnosis. 61
22648109 2012
222
Single-incision laparoscopic cholecystectomy versus traditional four-port cholecystectomy. 61
23077377 2012
223
Update on biliary and pancreatic sphincterotomy. 61
22782017 2012
224
Low but significant yield of endosonography in patients with suspected Sphincter of Oddi Dysfunction Type III with normal imaging studies. 61
23012668 2012
225
Association between volume of endoscopic retrograde cholangiopancreatography at an academic medical center and use of pancreatobiliary therapy. 61
22387254 2012
226
The diagnosis and management of Sphincter of Oddi dysfunction: a systematic review. 61
22688754 2012
227
Quantitative cholescintigraphy with fatty meal in the diagnosis of sphincter of Oddi dysfunction and acalculous cholecystopathy. 61
22941730 2012
228
Hybrid single-port cholecystectomy in children. 61
23318065 2012
229
Concomitant gastroparesis negatively affects children with functional gallbladder disease. 61
22588599 2012
230
Intermediate results of a prospective randomized controlled trial of traditional four-port laparoscopic cholecystectomy versus single-incision laparoscopic cholecystectomy. 61
22083331 2012
231
Multivisceral ex vivo surgery for tumors involving celiac and superior mesenteric arteries. 61
22300017 2012
232
How to interpret a functional or motility test - sphincter of oddi manometry. 61
22523732 2012
233
Medical treatment for sphincter of oddi dysfunction: can it replace endoscopic sphincterotomy? 61
22529689 2012
234
A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. 61
22494121 2012
235
Total pancreatectomy and islet autotransplantation for chronic pancreatitis. 61
22397977 2012
236
Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography. 61
22529693 2012
237
Laparoscopic subtotal colectomy with transrectal extraction of the colon and ileorectal anastomosis. 61
21938571 2012
238
Guidewire biliary cannulation does not reduce post-ERCP pancreatitis compared with the contrast injection technique in low-risk and high-risk patients. 61
22075192 2012
239
Cholangiographic features in opium-addicted patients at a tertiary hospital in iran. 61
23118744 2012
240
[A modern look at benign stenosing lesions. Etiology and pathogenesis of diagnostic capabilities. A systematic review]. 61
23402195 2012
241
Biliary dyskinesia: how effective is cholecystectomy? 61
22042565 2012
242
Quality of life after laparoscopic cholecystectomy for biliary dyskinesia in the pediatric population: a pilot study. 61
22273327 2012
243
Clinical characteristics and risk factors for symptomatic pediatric gallbladder disease. 61
22157135 2012
244
Current knowledge on pancreaticobiliary reflux in normal pancreaticobiliary junction. 61
22361306 2012
245
Evaluation of gastrointestinal pathology and treatment in children with suspected biliary dyskinesia. 61
21706177 2011
246
How to prevent post-ERCP pancreatitis? 61
22319964 2011
247
Ultrasound evaluation of gallbladder dyskinesia: comparison of scintigraphy and dynamic 3D and 4D ultrasound techniques. 61
22021502 2011
248
Prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate. 61
21487771 2011
249
Is biliary scintigraphy a reliable diagnostic tool for biliary dyskinesia in children? 61
21921844 2011
250
Suspected bile duct injuries and appropriate early referral can reduce chances of litigation. 61
22073708 2011
251
Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia. 61
21896203 2011
252
Predictors of complications after endoscopic retrograde cholangiopancreatography: a prognostic model for early discharge. 61
21455806 2011
253
Use of udenafil is not associated with a reduction in post-ERCP pancreatitis: results of a randomized, placebo-controlled, multicenter trial. 61
21802079 2011
254
The effects of morphine-neostigmine and secretin provocation on pancreaticobiliary morphology in healthy subjects: a randomized, double-blind crossover study using serial MRCP. 61
21656308 2011
255
Single-incision laparoscopic cholecystectomy: a comparison with the gold standard. 61
21487878 2011
256
Spotlight on sphincter of Oddi dysfunction. 61
21765328 2011
257
Laparoscopic transgastric endoscopic retrograde cholangiopancreatography (ERCP) after gastric bypass: case series and a description of technique. 61
21416184 2011
258
Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma. 61
21609370 2011
259
Outcomes after laparoscopic cholecystectomy in children with biliary dyskinesia. 61
21654301 2011
260
Pathologic changes in biliary dyskinesia. 61
21616245 2011
261
Periampullary choledochal diverticula are not choledochal cysts. 61
21439566 2011
262
Biliary sphincter of Oddi dysfunction: response rates after ERCP and sphincterotomy in a 5-year ERCP series and proposal for new practical guidelines. 61
21383625 2011
263
After all these years of SOD and endotherapy--how far have we come? The role of endoscopic treatment for acute recurrent pancreatitis (ARP) with sphincter of Oddi dysfunction (SOD). 61
21365517 2011
264
An unusual cause of double duct sign. Type I sphincter of Oddi dysfunction due to chronic opium addiction. 61
21288797 2011
265
Long-term results (≥ 10 years) of endoscopic therapy for sphincter of Oddi dysfunction in patients with acute recurrent pancreatitis. 61
21108172 2011
266
Botulinum toxin-induced relaxation of the sphincter of Oddi may select patients with acalculous biliary pain who will benefit from cholecystectomy. 61
20665051 2011
267
Prospective randomized controlled trial of traditional laparoscopic cholecystectomy versus single-incision laparoscopic cholecystectomy: report of preliminary data. 61
21367381 2011
268
Transforming growth factor α levels in pancreatic fluid. 61
21404459 2011
269
The cholecystokin provocation HIDA test: recreation of symptoms is superior to ejection fraction in predicting medium-term outcomes. 61
20824367 2011
270
[Oxygen-dependent processes in the blood cells from children with arterial hypertension concomitant with biliary dyskinesia]. 61
21509983 2011
271
Biliary dyskinesia as a rare presentation of metastatic breast carcinoma of the gallbladder: a case report. 61
22937393 2011
272
[A prospective evaluation of laparoscopic cholecystectomy in the treatment of chronic cholelithiasis--a five-year experience]. 61
21548274 2011
273
Cystic duct remnant syndrome. 61
21915383 2011
274
The non-conventional use of 99mTc-Tetrofosmine for dynamic hepatobiliary scintigraphy. 61
22219147 2011
275
Long-term symptomatic relief following surgical sphincteroplasty for sphincter of Oddi dysfunction. 61
21921631 2011
276
Management of patients with sphincter of Oddi dysfunction based on a new classification. 61
21253400 2011
277
Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases. 61
21894057 2011
278
Outcomes of sphincter of oddi manometry when performed in low volumes. 61
21747651 2011
279
Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study. 61
22185981 2011
280
Response to: Laparoscopic cholecystectomy is safe and effective for the treatment of biliary dyskinesia in the pediatric population. 61
21265362 2010
281
Sincalide infusion parameters: key information in a biliary dyskinesia clinical study. 61
21140705 2010
282
Challenges in planning and initiating a randomized clinical study of sphincter of Oddi dysfunction. 61
21034899 2010
283
Biliary causes of postcholecystectomy syndrome. 61
18722735 2010
284
Measuring episodic abdominal pain and disability in suspected sphincter of Oddi dysfunction. 61
20845508 2010
285
Single-incision laparoscopic cholecystectomy is feasible: initial experience with 80 cases. 61
20198490 2010
286
Biliary stent placement is associated with post-ERCP pancreatitis. 61
20633882 2010
287
Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy. 61
20662790 2010
288
Initial experience with single-incision laparoscopic cholecystectomy. 61
20698374 2010
289
[Chrono- and reflexotherapy for the treatment of the biliary tract dysfunctions]. 61
21086595 2010
290
Biliary microlithiasis, sludge, crystals, microcrystallization, and usefulness of assessment of nucleation time. 61
20525550 2010
291
Cholecystectomy using single-incision pediatric endosurgery: technique and initial experience in the first 25 cases. 61
20459327 2010
292
Extended application of 99mTc-mebrofenin cholescintigraphy with cholecystokinin in the evaluation of abdominal pain of hepatobiliary and gastrointestinal origin. 61
20147863 2010
293
Frequency of sphincter of Oddi dysfunction in patients with previously normal sphincter of Oddi manometry studies. 61
19967632 2010
294
The influence of variable-stiffness guide wires on basal biliary sphincter of Oddi pressure measured at endoscopic retrograde cholangiopancreatography. 61
20425665 2010
295
Prophylaxis of post-ERCP pancreatitis: a practice survey. 61
20226455 2010
296
Post-cholecystectomy syndrome: spectrum of biliary findings at magnetic resonance cholangiopancreatography. 61
20335441 2010
297
Biliary fascioliasis mimicking sphincter of Oddi dysfunction. 61
20224481 2010
298
Sphincter of Oddi dysfunction. 61
20424985 2010
299
Biliary sphincter of Oddi dysfunction type I versus occult biliary microlithiasis in post-cholecystectomy patients: are they both part of the same clinical entity? 61
19337835 2010
300
Laparoscopy-assisted transjejunal ERCP in a patient with Roux-en-Y reconstruction following partial gastrectomy. 61
19792864 2010
301
Needle-knife sphincterotomy: factors predicting its use and the relationship with post-ERCP pancreatitis (with video). 61
20003969 2010
302
Endoscopic retrograde cholangiopancreatography and manometry findings in 1,241 idiopathic pancreatitis patients. 61
20720445 2010
303
[Features of connective tissue dysplasia and prognosis of chronic gastroduodenal diseases in children of school age]. 61
20405712 2010
304
Microbiologic evaluation of gallbladder bile of healthy dogs and dogs with iatrogenic hypercortisolism: a pilot study. 61
19925578 2010
305
[Functional status of the bile excretion system and upper gastrointestinal tract in patients with duodenal ulcer]. 61
20626104 2010
306
Is there a benefit to delaying cholecystectomy for symptomatic gallbladder disease during pregnancy? 61
19517178 2010
307
Implanted estrogen pellets associated with hypertriglyceridemia, biliary dyskinesia and focal nodular hyperplasia of the liver: a case report. 61
20337216 2010
308
Sulphate-bicarbonate mineral waters in the treatment of biliary and digestive tract diseases. 61
20499033 2010
309
Laparoscopy-assisted ERCP: experience of a high-volume bariatric surgery center (with video). 61
19846085 2009
310
Sphincter of Oddi dysfunction: psychosocial distress correlates with manometric dyskinesia but not stenosis. 61
20027681 2009
311
Surgical gastrostomy for pancreatobiliary and duodenal access following Roux en Y gastric bypass. 61
19777312 2009
312
Investigation of Oddi sphincter structure by optical coherence tomography in patients with biliary-type 1 dysfunction: a pilot in vivo study. 61
19403347 2009
313
Diagnostic yield of ERCP and secretin-enhanced MRCP and EUS in patients with acute recurrent pancreatitis of unknown aetiology. 61
19278909 2009
314
Sphincter of Oddi: Function, dysfunction, and its management. 61
19799700 2009
315
Biliary MR imaging with Gd-EOB-DTPA and its clinical applications. 61
19959517 2009
316
[Unexplained acute pancreatitis: the microlithiasis must be searched?]. 61
20069159 2009
317
Endoscopic pancreatic sphincterotomy: indications and complications. 61
19721854 2009
318
Sphincter of Oddi dysfunction after Roux-en-Y gastric bypass. 61
19356993 2009
319
Single-port transumbilical laparoscopic cholecystectomy: a preliminary study in 37 patients with gallbladder disease. 61
19630589 2009
320
The use of tenoten preparation in complex therapy of hypomotoric biliary dyskinesia. 61
20027368 2009
321
Efficacy of intramuscular diclofenac and fluid replacement in prevention of post-ERCP pancreatitis. 61
19705494 2009
322
Prospective trial comparing solid-state catheter and water-perfusion triple-lumen catheter for sphincter of Oddi manometry done at the time of ERCP. 61
19386306 2009
323
Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. 61
19286178 2009
324
The learning curve with single-port cholecystectomy. 61
19793472 2009
325
Endoscopic retrograde cholangiopancreatography gut perforations: when to wait! When to operate! 61
19545095 2009
326
The feasibility and reliability of using circular electrode for sphincter of Oddi electromyography in anaesthetised rabbits. 61
19210627 2009
327
[Pancreatic sphincter of oddi dysfunction]. 61
19556838 2009
328
Levitra for sphincter of Oddi dysfunction? Are you kidding? 61
19410043 2009
329
Effects of vardenafil, a phosphodiesterase type-5 inhibitor, on sphincter of Oddi motility in patients with suspected biliary sphincter of Oddi dysfunction. 61
19243765 2009
330
The key event of acute pancreatitis: pancreatic duct obstruction and bile reflux, not a single one can be omitted. 61
19147295 2009
331
Interventions used with cholescintigraphy for the diagnosis of hepatobiliary disease. 61
19341837 2009
332
Single port access (SPA) cholecystectomy: a completely transumbilical approach. 61
19260790 2009
333
Alcohol use and cigarette smoking as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis. 61
19168153 2009
334
Postcholecystectomy syndrome - an algorithmic approach. 61
19337637 2009
335
A case of bone metaplasia of the gallbladder epithelium. 61
19204638 2009
336
Can wire-guided cannulation prevent post-ERCP pancreatitis? A prospective randomized trial. 61
19007927 2009
337
Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis. 61
19691794 2009
338
Cholecystectomy for suspected gallbladder dyskinesia. 61
19160318 2009
339
Biliary dyskinesia. 61
18992594 2008
340
Laparoscopic cholecystectomy for treatment of biliary dyskinesia is safe and effective in the pediatric population. 61
19062663 2008
341
Somatosensory hypersensitivity in the referred pain area in patients with chronic biliary pain and a sphincter of Oddi dysfunction: new aspects of an almost forgotten pathogenetic mechanism. 61
18684173 2008
342
Evaluation of surgical outcomes and gallbladder characteristics in patients with biliary dyskinesia. 61
18543048 2008
343
Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial. 61
18680075 2008
344
Prospective evaluation of adjunctive ketamine on sphincter of Oddi motility in humans. 61
17593222 2008
345
Sphincter of Oddi hypomotility and its relationship with duodenal-biliary reflux, plasma motilin and serum gastrin. 61
18609694 2008
346
Laparoscopic cholecystectomy for biliary dyskinesia in children: report of 100 cases from a single institution. 61
18646475 2008
347
[Role of somatotropin in the development of functional diseases of the digestive system in adolescents]. 61
19253738 2008
348
Use of laparoscopic cholecystectomy for biliary dyskinesia in the child. 61
18558182 2008
349
Biliary dyskinesia in the pediatric patient. 61
18625146 2008
350
Laparoscopic cholecystectomy for biliary dyskinesia in children provides durable symptom relief. 61
18558183 2008
351
Prognostic indicators of quality of life after cholecystectomy for biliary dyskinesia. 61
18481495 2008
352
Paediatric cholecystectomy: Shifting goalposts in the laparoscopic era. 61
17593453 2008
353
Transduodenal sphincteroplasty in the management of sphincter of Oddi dysfunction and pancreas divisum in the modern era. 61
18471721 2008
354
Comparison of secretin-stimulated magnetic resonance pancreatography and manometry results in patients with suspected sphincter of oddi dysfunction. 61
18423317 2008
355
A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis. 61
18389448 2008
356
Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future? 61
21960915 2008
357
Sphincter of Oddi dysfunction in hypercholesterolemic rabbits. 61
18301301 2008
358
Endoscopic ultrasonography for evaluating patients with recurrent pancreatitis. 61
18286681 2008
359
Laparoscopic cholecystectomy in the pediatric population. 61
18266591 2008
360
Endoscopic therapy in acute recurrent pancreatitis. 61
18286684 2008
361
Sphincter of Oddi dysfunction and bile duct microlithiasis in acute idiopathic pancreatitis. 61
18286682 2008
362
Pancreatic duct stent placement prevents post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction but normal manometry results. 61
18028920 2008
363
Pancreatic ductal system obstruction and acute recurrent pancreatitis. 61
18286683 2008
364
Biliary tract complications after liver transplantation: a review. 61
18628624 2008
365
Management of biliary complications after orthotopic liver transplantation: the role of endoscopy. 61
18203278 2008
366
Is endoscopic sphincterotomy avoidable in patients with sphincter of Oddi dysfunction? 61
18090984 2008
367
Efficacy and tolerance of metamizole versus morphine for acute pancreatitis pain. 61
18235213 2008
368
MR imaging of the gallbladder: a pictorial essay. 61
18203935 2008
369
A retrospective assessment of magnetic resonance cholangiopancreatography in children. 61
18162835 2008
370
[Cholagenic diarrhea]. 61
18372593 2008
371
Efficacy of laparoscopic cholecystectomy in the pediatric population. 61
18206466 2008
372
[Clinicoepidemiological features of echinococcosis in men serving in the navy]. 61
18326232 2008
373
Role of endoscopic retrograde cholangiopancreatography in acute pancreatitis. 61
18081218 2007
374
Sphincter of Oddi dysfunction and pancreatitis. 61
18081221 2007
375
Diagnosis and management of sphincter of Oddi dysfunction and pancreas divisum. 61
18053839 2007
376
Sphincter of Oddi dysfunction in children with recurrent abdominal pain: 5-year follow-up after endoscopic sphincterotomy. 61
18031389 2007
377
Opium addiction as a new risk factor of sphincter of Oddi dysfunction. 61
17968302 2007
378
Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. 61
17981248 2007
379
Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology. 61
17619882 2007
380
Accessing the common bile duct after Roux-en-Y gastric bypass. 61
17690021 2007
381
The morphine-prostigmine provocation (Nardi) test for sphincter of Oddi dysfunction: results in healthy volunteers and in patients before and after transduodenal sphincteroplasty and transampullary septectomy. 61
17872575 2007
382
Health-related quality of life, somatization, and abuse in Sphincter of Oddi dysfunction. 61
17700426 2007
383
Sphincter of oddi dysfunction: stones, spasm, or stenosis? 61
21960884 2007
384
Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. 61
17703388 2007
385
Choledocholithiasis mimicking sphincter of oddi dysfunction. 61
21960883 2007
386
Biliary and gallbladder dyskinesia. 61
17761125 2007
387
Pancreatic sphincterotomy: technique, indications, and complications. 61
17696223 2007
388
Early successes and late failures in the prevention of post endoscopic retrograde cholangiopancreatography. 61
17659706 2007
389
ERCP in acute pancreatitis. 61
17548244 2007
390
Relationship between intraduodenal peri-ampullary diverticulum and biliary disease in 178 patients undergoing ERCP. 61
17548255 2007
391
Prospective comparison of secretin-stimulated magnetic resonance cholangiopancreatography with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III. 61
17005767 2007
392
Prospective comparison of secretin-stimulated MRCP with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III. 61
17519477 2007
393
Solid state biliary manometry catheter: impact on diagnosis and post-study pancreatitis. 61
17418064 2007
394
Predicting pancreas divisum by inspection of the minor papilla: a prospective study. 61
17413614 2007
395
[Morpho-functional status of the hypophysial-thyroidal system in patients with functional disorders of the digestive tract]. 61
18271182 2007
396
Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification. 61
17321236 2007
397
Management of biliary complications following orthotopic liver transplantation. 61
17335675 2007
398
Technology insight: applications of MRI for the evaluation of benign disease of the pancreas. 61
17339852 2007
399
Secretin-stimulated magnetic resonance cholangiopancreatography of patients with unclear disease in the pancreaticobiliary tract. 61
17354131 2007
400
Postcholecystectomy sphincter of oddi dyskinesia--a diagnostic dilemma--role of noninvasive nuclear and invasive manometric and endoscopic aspects. 61
17318046 2007
401
The effect of biliary sphincterotomy on serum cholesterol level in postcholecystectomy patients: a pilot study. 61
17299610 2007
402
[Contemporary approaches to evaluation of psychosomatic status in patients with alimentary tract diseases]. 61
17419360 2007
403
[Functional condition of the hepatobiliary system in patients with biliary dyskinesia]. 61
17460967 2007
404
Diagnosis and treatment of sphincter of oddi dysfunction. 61
21960774 2007
405
Predictors of outcomes after biliary and pancreatic sphincterotomy for sphincter of oddi dysfunction. 61
17198071 2007
406
Prevalence of sphincter of Oddi dysfunction in patients referred to endoscopic retrograde cholangiopancreatography. 61
17639177 2007
407
Down regulated expression of the beta1 subunit of the big-conductance Ca2+ sensitive K+ channel in sphincter of Oddi cells from rabbits fed with a high cholesterol diet. 61
17151783 2006
408
A comparison of cholecystectomy and observation in children with biliary dyskinesia. 61
17101366 2006
409
Pull or push pancreatic sphincterotomy for sphincter of Oddi dysfunction? A conundrum for experts only. 61
17055864 2006
410
Characterization of functional biliary pain and dyspeptic symptoms in patients with sphincter of Oddi dysfunction: effect of papillotomy. 61
17106935 2006
411
[Endoscopic pancreatic sphincterotomy: when and how]. 61
17129553 2006
412
Gallbladder wall inflammatory cells in pediatric patients with biliary dyskinesia and cholelithiasis: a pilot study. 61
16952589 2006
413
Ultrasonographic evaluation of fatty meal stimulated gallbladder contraction in the diagnosis of biliary dyskinesia in children. 61
16801181 2006
414
[Low temperature peloid therapy for sanatorium treatment of biliary dyskinesia]. 61
16989204 2006
415
A survey of physician practices on prophylactic pancreatic stents. 61
16813802 2006
416
Systematic review: sphincter of Oddi dysfunction--non-invasive diagnostic methods and long-term outcome after endoscopic sphincterotomy. 61
16842450 2006
417
Sphincter of Oddi dysfunction: managing the patient with chronic biliary pain. 61
16804961 2006
418
[Some features of functional gastroenterological diseases in young people]. 61
17100238 2006
419
Role of endoscopic evaluation in idiopathic pancreatitis: a systematic review. 61
16733122 2006
420
[The health status of pupils from different-profile schools]. 61
16808409 2006
421
Endoscopic management of sphincter of Oddi dysfunction in children. 61
16707975 2006
422
Evaluation of the biliary tract in patients with functional biliary symptoms. 61
16718807 2006
423
Sphincter of Oddi dysfunction in children. 61
16533481 2006
424
Biliary dyskinesia in pediatrics. 61
16533482 2006
425
Functional hepatobiliary disease: chronic acalculous gallbladder and chronic acalculous biliary disease. 61
16517234 2006
426
Botulinum toxin for gastrointestinal disorders: therapy and mechanisms. 61
16785113 2006
427
Assessment of the reproducibility of quantitative hepatobiliary scintigraphy (QHBS) in patients with sphincter of Oddi dysfunction (SOD)--inappropriate method or intermittent disease? 61
16608015 2006
428
Bio-sensor system discriminating between the biliary and pancreatic ductal systems. 61
16937166 2006
429
CCK1 antagonists: are they ready for clinical use? 61
16699265 2006
430
Risk factors for post-ERCP pancreatitis: a prospective multicenter study. 61
16405547 2006
431
Recent developments in gastrointestinal motility. 61
16782619 2006
432
Prolonged urinary incontinence and biliary dyskinesia following abdominal contact with jellyfish tentacles. 61
17078314 2006
433
The role of endoscopic retrograde cholangiopancreatography and endoscopic ultrasound in diagnosis and treatment of acute pancreatitis. 61
16282957 2005
434
The underestimated role of opiates in patients with suspected sphincter of Oddi dysfunction after cholecystectomy. 61
16518275 2005
435
Diagnostic challenge of sphincter of oddi dysfunction in postcholecystectomy pain syndromes. 61
16295829 2005
436
Pre-cut papillotomy with a new papillotome. 61
16185974 2005
437
Surgical therapy for biliary dyskinesia: a meta-analysis and review of the literature. 61
16185113 2005
438
Biliary dyskinesia: the most common indication for cholecystectomy in children. 61
16269302 2005
439
Diagnostic and therapeutic endoscopic retrograde cholangiopancreatography in children: a large series report. 61
16205513 2005
440
Controversies concerning pathophysiology and management of acalculous biliary-type abdominal pain. 61
16110827 2005
441
[Sphincter of Oddi dysfunction]. 61
16294153 2005
442
[Endoscopic management of biliary complications after liver transplantation]. 61
17469414 2005
443
Sphincter of Oddi dysfunction: overdue for an overhaul. 61
15929746 2005
444
Intrapancreatic ductal pressure in sphincter of Oddi dysfunction. 61
15841048 2005
445
Surgical sphincteroplasty in 446 patients. 61
15897447 2005
446
Biliary complications in liver transplant recipients. 61
15802106 2005
447
Pancreatitis due to codeine. 61
15946633 2005
448
Is sphincter of Oddi manometry a risk factor for pancreatitis? A different view. 61
15802103 2005
449
Endoscopic Biliary and Pancreatic Sphincterotomy. 61
15769434 2005
450
Sphincter of Oddi Dysfunction. 61
15769432 2005
451
Diagnostic endoscopic retrograde cholangiopancreatography. 61
15692928 2005
452
Therapeutic biliary endoscopy. 61
15692929 2005
453
Biliary disease after liver transplantation: the experience of the King Faisal Specialist Hospital and Research Center, Riyadh. 61
15683424 2005
454
Experience on endoscopic retrograde cholangiopancreatography at tertiary referral center in Thailand: risks and complications. 61
15962677 2005
455
A new mechanism for diverticular diseases: aging-related vagal withdrawal. 61
15607549 2005
456
[Clinical and biochemical characteristics of biliferous tract diseases in patients with diabetes mellitus]. 61
15941142 2005
457
Gastric perforation secondary to ingestion of a sharp foreign body. 61
15791979 2005
458
[Use of grandaxin in hypermotor dysfunction of the biliary ducts in young people]. 61
17378391 2005
459
Biliary dyskinesia: a brief review. 61
15475088 2004
460
Improved predictors of outcome in postcholecystectomy pain. 61
15319654 2004
461
Sphincter of Oddi manometry in patients with acute biliary pancreatitis: evidence for sphincter of Oddi dysfunction in acute biliary pancreatitis. 61
15370694 2004
462
Predictors of successful outcome after cholecystectomy for biliary dyskinesia. 61
15185202 2004
463
Needle-knife suprapapillary sphincterotomy avoids postprocedure pancreatitis in patients with sphincter of Oddi dysfunction of biliary type II: a report of three cases. 61
14973727 2004
464
Sphincter of Oddi dysfunction, part 2: Evidence-based review of the presentations, with "objective" pancreatic findings (types I and II) and of presumptive type III. 61
15114311 2004
465
An evidence-based review of sphincter of Oddi dysfunction: part I, presentations with "objective" biliary findings (types I and II). 61
15044889 2004
466
Intestinal dysmotility and its relationship to sphincter of Oddi dysfunction. 61
15191693 2004
467
Diagnosing and treating Sphincter of Oddi dysfunction: a critical literature review and reevaluation. 61
15087695 2004
468
Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. 61
15067627 2004
469
Sphincter of Oddi manometry does not predispose to post-ERCP acute pancreatitis. 61
15044885 2004
470
[Effect of biliary dyskinesia on ischemic heart disease progression]. 61
15318827 2004
471
[Clinical efficacy of corinfar retard in the treatment of patients with biliary tract dyskinesia]. 61
15208881 2004
472
[Evaluation of endoscopic sphincter of Oddi manometry in patients with biliopancreatic diseases]. 61
15011439 2004
473
Biliary dyskinesia: is the problem with Oddi? 61
14770323 2004
474
Therapeutic efficacy of laparoscopic cholecystectomy in the treatment of biliary dyskinesia. 61
14769306 2004
475
The use of botulinum toxin for the treatment of gastrointestinal motility disorders. 61
15104353 2004
476
Suspected sphincter of Oddi dysfunction type II: empirical biliary sphincterotomy or manometry-guided therapy? 61
14765316 2004
477
Sphincter of Oddi dysfunction: cut and inject, but don't measure the pressure? 61
14765317 2004
478
Botulinum toxin injection after biliary sphincterotomy. 61
14765315 2004
479
True culprit or guilt by association? Is sphincter of Oddi manometry the cause of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction, or is it the patients' susceptibility? 61
15580155 2004
480
Scintigraphic sign of functional biliary obstruction is pathognomic for sphincter of Oddi dysfunction. 61
15011834 2004
481
Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. 61
14722540 2004
482
Therapeutic pancreatic endoscopy. 61
14722850 2004
483
[New approaches to diagnosing and treating hyperkinetic biliary dyskinesia associated with chronic acalculous cholecystitis]. 61
15540426 2004
484
Frequency of biliary crystals in patients with suspected sphincter of Oddi dysfunction. 61
14652556 2003
485
Secretin MRCP and endoscopic pancreatic manometry in the evaluation of sphincter of Oddi function: a comparative pilot study in patients with idiopathic recurrent pancreatitis. 61
14652551 2003
486
Prospective evaluation of droperidol on sphincter of Oddi motility. 61
14520277 2003
487
Key issues in sphincter of Oddi dysfunction. 61
14986793 2003
488
Motility and dysmotility of the biliary tract. 61
14719770 2003
489
Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. 61
14551860 2003
490
Is hepatobiliary scintigraphy indeed insensitive for the diagnosis of sphincter of Oddi dysfunction? 61
12912877 2003
491
Is hepatobiliary scintigraphy insensitive for the diagnosis of sphincter of Oddi dysfunction? 61
12912878 2003
492
Determination of sphincter of Oddi dysfunction in patients with prior normal manometry. 61
14528205 2003
493
Laparoscopic resection of focal nodular hyperplasia. 61
12960793 2003
494
Incomplete response to endoscopic sphincterotomy in patients with sphincter of Oddi dysfunction: evidence for a chronic pain disorder. 61
12907327 2003
495
Acalculous biliary pain: new concepts for an old entity. 61
12974505 2003
496
Outcomes of surgical therapy for biliary dyskinesia. 61
14506824 2003
497
Sphincter of Oddi dysfunction. 61
12974506 2003
498
Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study. 61
12838216 2003
499
Sphincter of Oddi dysfunction and other functional biliary disorders: evaluation and treatment. 61
12858608 2003
500
The relationship of bile duct crystals to sphincter of Oddi dysfunction. 61
12631458 2003
501
Meperidine misuse in a patient with sphincter of Oddi dysfunction. 61
12659611 2003
502
Noninvasive imaging for diagnosis of sphincter of Oddi dysfunction. 61
12631455 2003
503
Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram. 61
12665757 2003
504
Biliary emergencies: pancreatitis, cholangitis, and more. 61
12889582 2003
505
Effect of nalbuphine on the motility of the sphincter of Oddi in patients with suspected sphincter of Oddi dysfunction. 61
12612509 2003
506
Scintigraphy versus manometry in patients with suspected biliary sphincter of Oddi dysfunction. 61
12584215 2003
507
Oddi's sphincter dysfunction. 61
16481969 2003
508
Therapeutic biliary endoscopy. 61
12561009 2003
509
Endoscopic diagnosis and treatment of post-cholecystectomy syndrome. 61
14607662 2003
510
Acute idiopathic pancreatitis: does it really exist or is it a myth? 61
14743894 2003
511
[Psychovegetative features in patients with biliary dyskinesia]. 61
14520946 2003
512
New frontiers in the pharmacological prevention of post-ERCP pancreatitis: the cytokines. 61
12555016 2003
513
The sphincter of Oddi and acute pancreatitis--revisited. 61
18332974 2003
514
Sphincter of Oddi dysfunction and the anomalous pancreaticobiliary junction. 61
14598143 2003
515
The effect of transcutaneous nerve stimulation on intraductal biliary pressure in post-cholecystectomy patients with T-drainage. 61
12544690 2003
516
Mechanical prevention of post-ERCP pancreatitis by pancreatic stents: results, techniques, and indications. 61
12555017 2003
517
What is the role of ERCP in the setting of abdominal pain of pancreatic or biliary origin (suspected sphincter of Oddi dysfunction)? 61
12447279 2002
518
Complications of endoscopic sphincterotomy: results from a single tertiary referral center. 61
12471544 2002
519
Gallbladder disease: an update on diagnosis and treatment. 61
12546270 2002
520
[Sphincter of Oddi dysfunction--prolonged medical therapy or early endoscopic sphincter ablation]. 61
12638309 2002
521
Gallbladder function before and after fundoplication. 61
12504218 2002
522
Prevalence of sphincter of Oddi dysfunction: can results from specialized centers be generalized? 61
12452371 2002
523
Pseudomonas aeruginosa liver abscesses after diagnostic endoscopic retrograde cholangiography in two patients with sphincter of Oddi dysfunction type 2. 61
12085136 2002
524
Why the incidence of post-ERCP pancreatitis varies considerably? Factors affecting the diagnosis and the incidence of this complication. 61
12432186 2002
525
Risk factors for complications after performance of ERCP. 61
12397271 2002
526
Relative effects of dihydropyridine L-type calcium channel antagonism on biliary, duodenal, and vascular tissues: an in vivo and in vitro analysis in Australian brush-tailed possum. 61
12353851 2002
527
Biliary dyskinesia in children. 61
12415355 2002
528
Evaluation of unexplained acute and acute recurrent pancreatitis using endoscopic retrograde cholangiopancreatography, sphincter of Oddi manometry and endoscopic ultrasound. 61
12173081 2002
529
Biliary Dyskinesia. 61
12095476 2002
530
Control of port-site bleeding from smaller incisions after laparoscopic cholecystectomy surgery: a new, innovative, and easier technique. 61
12193814 2002
531
ERCP in patients with long-limb Roux-en-Y gastrojejunostomy and intact papilla. 61
12145601 2002
532
An assessment of the learning curve for precut biliary sphincterotomy. 61
12135022 2002
533
Bedside scoring system to predict the risk of developing pancreatitis following ERCP. 61
12048633 2002
534
Hepatobiliary scintigraphy as the diagnostic test for sphincter of Oddi dysfunction: pan the scan? 61
12094841 2002
535
Outcome of endoscopic sphincterotomy in post cholecystectomy patients with sphincter of Oddi dysfunction as predicted by manometry and quantitative choledochoscintigraphy. 61
11950813 2002
536
A controlled study of the effect of midazolam on abnormal sphincter of Oddi motility. 61
11979243 2002
537
Nontraumatic pancreatitis in spinal cord injury. 61
11979180 2002
538
The role of endoscopic retrograde cholangiopancreatography in acute and chronic pancreatitis. 61
11960071 2002
539
Evidence-based approach to idiopathic pancreatitis. 61
11900677 2002
540
[Usefulness of botulinum toxin in gastrointestinal disorders]. 61
12214336 2002
541
Sphincter of Oddi dysfunction: is there a role for medical therapy? 61
11900684 2002
542
Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. 61
11932782 2002
543
Sphincter of Oddi (pancreatic) hypertension and recurrent pancreatitis. 61
11900681 2002
544
ERCP-related perforations: risk factors and management. 61
11932784 2002
545
Octreotide relaxes the hypertensive sphincter of Oddi: pathophysiological and therapeutic implications. 61
11922555 2002
546
Sphincter of Oddi dysfunction in patients addicted to opium: an unrecognized entity. 61
11868024 2002
547
Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy. 61
11818927 2002
548
Bile duct crystals do not contribute to sphincter of Oddi dysfunction. 61
11818916 2002
549
Gastrointestinal uses of botulinum toxin. 61
11782604 2002
550
Gastrointestinal imaging update: swallowing disorders and sphincter of Oddi dysfunction. 61
12481168 2002
551
Transduodenal sphincteroplasty and transampullary septectomy for sphincter of Oddi dysfunction. 61
11890620 2002
552
Adverse outcomes of endoscopic retrograde cholangiopancreatography. 61
12481167 2002
553
[Choice of optimal vegetotropic drug therapy in patients with chronic non-calculous cholecystitis combined with gallbladder dyskinesia]. 61
12353391 2002
554
[A choice of optimal vegetotropic pharmacotherapy in patients with chronic non-calculous cholecystitis in combination with dyskinesia of the gallbladder]. 61
12046393 2002
555
NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. 61
14768653 2002
556
Advances in research and clinical practice in motor disorders of the sphincter of Oddi. 61
12541041 2002
557
[Gastrointestinal motility and vegetative balance: correlations in peptic ulcer]. 61
12360617 2002
558
Role of hepatobiliary scintigraphy in the evaluation and management of post-cholecystectomy pain due to biliary dyskinesia. 61
12148394 2002
559
Effect of somatostatin on the sphincter of Oddi in patients with acute non-biliary pancreatitis. 61
11709520 2001
560
Comparison of sphincter of Oddi manometry, fatty meal sonography, and hepatobiliary scintigraphy in the diagnosis of sphincter of Oddi dysfunction. 61
11726844 2001
561
Cholecystokinin-Stimulated mebrofenin (99mTc-Choletec) hepatobiliary scintigraphy in asymptomatic postcholecystectomy individuals: assessment of specificity, interobserver reliability, and reproducibility. 61
11721756 2001
562
Sphincter of Oddi dysfunction: diagnosis and treatment. 61
11880698 2001
563
Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. 61
11577302 2001
564
Recurrent Acute Pancreatitis. 61
11560783 2001
565
Idiopathic acute recurrent pancreatitis. 61
11569674 2001
566
Cholecystokinin cholescintigraphy: clinical indications and proper methodology. 61
11587066 2001
567
Endoscopic sphincterotomy for stenosis of the sphincter of Oddi. 61
11605112 2001
568
Endoscopic therapy after laparoscopic cholecystectomy. 61
11500611 2001
569
Correlation between sphincter of Oddi manometry and intraductal ultrasound morphology in patients with suspected sphincter of Oddi dysfunction. 61
11558031 2001
570
Prediction of pancreatitis following endoscopic retrograde cholangiopancreatography by the 4-h post procedure amylase level. 61
11555108 2001
571
Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial. 61
11421871 2001
572
Outcome of surgical treatment of chronic pancreatitis associated with sphincter of Oddi dysfunction. 61
11379650 2001
573
Indications and efficacy of botulinum toxin in disorders of the gastrointestinal tract. 61
11396545 2001
574
Radionuclide imaging of hepatic and biliary disease. 61
11436571 2001
575
Chronic Visceral Right Upper Quadrant Pain Without Gallstones. 61
11469970 2001
576
Efficacy of biliary scintigraphy in suspected sphincter of Oddi dysfunction. 61
11276385 2001
577
Concomitant manifestation of achalasia and sphincter of Oddi dysfunction. 61
11272221 2001
578
Hybrid classification of sphincter of Oddi dysfunction based on simplified Milwaukee criteria: effect of marginal serum liver and pancreas test elevations. 61
11281175 2001
579
Sphincter of Oddi dysfunction associated with choledochal cyst. 61
11207909 2001
580
Sphincterotomy for biliary sphincter of Oddi dysfunction. 61
11686993 2001
581
[Galstena efficacy in patients with biliary dyskinesia, chronic cholecystitis and cholelithiasis]. 61
11811112 2001
582
Hymecromone in the treatment of motor disorders of the bile ducts: a multicenter, double-blind, placebo-controlled clinical study. 61
11951580 2001
583
A brief commentary: electroacupuncture may relax the contraction of sphincter of Oddi. 61
11822626 2001
584
What are the risks of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography? 61
11147436 2000
585
A new source of drug-induced acute pancreatitis: codeine. 61
11095359 2000
586
Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of Oddi dysfunction. 61
11069318 2000
587
Sphincter of Oddi dysfunction produces acute pancreatitis in the possum. 61
10986215 2000
588
ERCP-induced Pancreatitis. 61
11096597 2000
589
Sphincter of Oddi dysfunction: two case reports and a review of the literature. 61
10983751 2000
590
Sphincter of oddi manometry: is it necessary to measure both biliary and pancreatic sphincter pressures? 61
10922088 2000
591
Idiopathic recurrent pancreatitis: long-term results after ERCP, endoscopic sphincterotomy, or ursodeoxycholic acid treatment. 61
10925971 2000
592
Quantitative hepatobiliary scintigraphy and endoscopic sphincter of Oddi manometry in patients with suspected sphincter of Oddi dysfunction: assessment of flow-pressure relationship in the biliary tract. 61
10929906 2000
593
Use of (99m)Tc-DISIDA biliary scanning with morphine provocation for the detection of elevated sphincter of Oddi basal pressure. 61
10807897 2000
594
A randomized, double-blind study of the use of droperidol for conscious sedation during therapeutic endoscopy in difficult to sedate patients. 61
10805839 2000
595
Pain associated with phase III of the duodenal migrating motor complex in patients with postcholecystectomy biliary dyskinesia. 61
10805836 2000
596
Therapeutic ERCP in the management of pancreatitis in children. 61
10744808 2000
597
Endoscopic retrograde cholangiopancreatography in the diagnosis and management of pancreatic diseases. 61
10981015 2000
598
Sphincter of Oddi dysfunction: the tales of two countries. 61
10981008 2000
599
Therapeutic pancreatic endoscopy. 61
10718387 2000
600
Failure of percutaneous catheter drainage of pancreatic pseudocyst. 61
10759195 2000
601
Cyclic motility of the sphincter of Oddi. 61
10982610 2000
602
Manometry based randomised trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction. 61
10601063 2000
603
Video manometry of the sphincter of Oddi: a new aid for interpreting manometric tracings and excluding manometric artefacts. 61
10691267 2000
604
Celiac disease and recurrent pancreatitis. 61
10570344 1999
605
Cholecystectomy is an effective treatment for biliary dyskinesia. 61
10670853 1999
606
Frequency of abnormal pancreatic and biliary sphincter manometry compared with clinical suspicion of sphincter of Oddi dysfunction. 61
10536318 1999
607
Sphincter of Oddi dysfunction after successful gallstone lithotripsy (postlithotripsy syndrome): manometric data and results of endoscopic sphincterotomy. 61
10573369 1999
608
Causes of acute and recurrent pancreatitis. Clinical considerations and clues to diagnosis. 61
10503137 1999
609
Sphincter of Oddi dysfunction in children with recurrent pancreatitis and anomalous pancreaticobiliary union: an etiologic concept. 61
10425412 1999
610
Laparoscopic cholecystectomy in children: lessons learned from the first 100 patients. 61
10466603 1999
611
[The effect of chelidonium- and turmeric root extract on upper abdominal pain due to functional disorders of the biliary system. Results from a placebo-controlled double-blind study]. 61
10495621 1999
612
Laparoscopy in the management of children with chronic recurrent abdominal pain. 61
10527334 1999
613
Pancreatic stenting after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. 61
10428614 1999
614
Intrasphincteric botulinum toxin type A for the diagnosis of sphincter of Oddi dysfunction: a case report. 61
10803999 1999
615
Same-day discharge after endoscopic biliary sphincterotomy: observations from a prospective multicenter complication study. The Multicenter Endoscopic Sphincterotomy (MESH) Study Group. 61
10228255 1999
616
[The efficacy of treatment by drinking sodium-potassium chloride mineral water in patients with chronic acalculous cholecystitis and biliary dyskinesia]. 61
10429572 1999
617
Cholecystectomy for suspected biliary dyskinesia in children with chronic abdominal pain. 61
10359195 1999
618
Botulinum toxin for spastic gastrointestinal disorders. 61
11030639 1999
619
Postcholecystectomy pain syndrome: pathophysiology of abdominal pain in sphincter of Oddi type III. 61
10092312 1999
620
The role of sphincter of oddi dysfunction in acute recurrent pancreatitis. 61
10980932 1999
621
Sphincter of Oddi dysfunction type III: another manifestation of visceral hyperalgesia? 61
10092325 1999
622
Visceral algesia in irritable bowel syndrome, fibromyalgia, and sphincter of oddi dysfunction, type III. 61
10080161 1999
623
Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry (SOM). 61
10022634 1999
624
Comparison of ultrasound-secretin test and sphincter of Oddi manometry in patients with recurrent acute pancreatitis. 61
10063920 1999
625
Laparoscopic cholecystectomy in an academic hospital: evaluation of changes in perioperative outcomes. 61
10323163 1999
626
Biliary complications of orthotopic liver transplantation. 61
10697662 1999
627
Dynamic imaging of the pancreas using real-time endoscopic ultrasonography with secretin stimulation. 61
9852447 1998
628
Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. 61
9834280 1998
629
Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. 61
9865560 1998
630
The utility of liver function test abnormalities concomitant with biliary symptoms in predicting a favorable response to endoscopic sphincterotomy in patients with presumed sphincter of Oddi dysfunction. 61
9772040 1998
631
Sphincter of Oddi dysfunction and acute pancreatitis. 61
9863467 1998
632
Biliary dyskinesia: a study of more than 200 patients and review of the literature. 61
9843604 1998
633
Dyspepsia in infants and children. 61
9890091 1998
634
The changing face of cholecystectomy. 61
9655275 1998
635
Hypertensive pancreatic sphincter. 61
9773212 1998
636
Hypoplasia of the left hepatic lobe associated with floating gallbladder: a case report. 61
9756014 1998
637
Biliary dyskinesia: natural history and surgical results. 61
9619167 1998
638
Diagnosis and treatment of sphincter of Oddi dysfunction. 61
9635801 1998
639
The influence of sphincterotomy and hepatic plexus vagotomy on ascending infections of the biliary tract: an experimental study in dogs. 61
9684113 1998
640
Re: Is endoscopic common bile duct stenting useful in patients with suspected sphincter of Oddi dysfunction? 61
9576475 1998
641
[Dysfunction of the sphincter of Oddi in cholecystectomy patients]. 61
9641013 1998
642
[Magnetic resonance cholangiopancreatography (MRCP) versus endoscopic retrograde cholangiopancreatography (ERCP): diagnostic usefulness]. 61
9633177 1998
643
[Role of cholangiopancreatography combined with magnetic resonance and hepatobiliary scintigraphy with 99mTc-HIDA in the assessment of biliary dyskinesia. Report of a case]. 61
9638178 1998
644
Pure cut electrocautery current for sphincterotomy causes less post-procedure pancreatitis than blended current. 61
9512280 1998
645
Laparoscopic cholecystectomy alleviates pain in patients with acalculous biliary disease. 61
9488567 1998
646
Cholecystectomy in cardiothoracic organ transplant recipients. 61
9438763 1998
647
Two unusual cases of postcholecystectomy pain. 61
9419306 1998
648
Biliary motility disorders. 61
9512807 1997
649
Is endoscopic common bile duct stenting useful in patients with suspected sphincter of Oddi dysfunction? 61
9362219 1997
650
[Endoscopic manometry of Oddi's sphincter]. 61
9609056 1997
651
Tilidine does not affect human sphincter of Oddi motility--a randomized, controlled study. 61
9354211 1997
652
[The treatment of patients with chronic cholecystitis and hypomotor biliary dyskinesia at a sanatorium]. 61
9446306 1997
653
Somatization disorder in sphincter of Oddi dysfunction. 61
9316189 1997
654
Trends in management of gallbladder disorders in children. 61
9244096 1997
655
Small bowel dysmotility in patients with postcholecystectomy sphincter of Oddi dysfunction. 61
9246055 1997
656
Sphincter of Oddi dysfunction is associated with chronic pancreatitis. 61
9219783 1997
657
Discordance of pressure recordings from biliary and pancreatic duct segments in patients with suspected sphincter of Oddi dysfunction. 61
9246054 1997
658
[Risk factors in endoscopic manometry for suspected dysfunction of Oddi's sphincter]. 61
9244668 1997
659
Cholelithiasis, cholecystitis, and common bile duct stones. 61
9229169 1997
660
[Do ultrasound parameters allow diagnosis of biliary sphincter of Oddi dysfunction?]. 61
9281239 1997
661
Complications of endoscopic biliary sphincterotomy: a review. 61
9255535 1997
662
Endoscopic bile duct stent placement as a predictor of outcome following endoscopic sphincterotomy in patients with suspected sphincter of Oddi dysfunction. 61
9187879 1997
663
Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. 61
9255527 1997
664
Botulinum toxin injection as a diagnostic tool for verification of sphincter of Oddi dysfunction causing recurrent pancreatitis. 61
9101150 1997
665
[Chronic cholecystitis--some lithogenic aspects]. 61
9173571 1997
666
Causes and management of recurrent biliary pain after successful nonoperative gallstone treatment. 61
8995953 1997
667
Biliary dyskinesia and biliary crystals: a prospective study. 61
8985075 1997
668
Gallbladder dyskinesia in children. 61
9876649 1997
669
[Thermal vibromassage in the treatment of children with dyskinesia of the biliary tract]. 61
9190746 1997
670
[Liver in children with prior intrathoracic tuberculosis during long-term observation period after chemotherapy]. 61
9503926 1997
671
Effect of octreotide on sphincter of Oddi motility in patients with acute recurrent pancreatitis: a manometric study. 61
9011448 1996
672
Does intrabiliary pressure predict basal sphincter of Oddi pressure? A study in patients with and without gallbladders. 61
8979060 1996
673
Biliary dyskinesia in idiopathic slow-transit constipation. 61
8918444 1996
674
[Biliary dyskinesia: is the study of the Oddi's sphincter motility useful?]. 61
9102792 1996
675
Outpatient therapeutic ERCP: a series of 262 consecutive cases. 61
8905366 1996
676
Sphincter of Oddi dysfunction. 61
8872520 1996
677
Biopsies of the ampullary region in sphincter of Oddi dysfunction. 61
8858335 1996
678
[Esophagus and anorectal motility in patients with dysfunction of Oddi's sphincter]. 61
8967121 1996
679
Motility of Oddi's sphincter: recent developments and clinical applications. 61
8686801 1996
680
[Sphincter of Oddi disfunction in "idiopathic" recurrent pancreatitis]. 61
8654212 1996
681
Effect of erythromycin on human biliary motility. 61
8791972 1996
682
Endoscopic diagnosis and management of biliary complications following orthotopic liver transplantation. 61
8654132 1996
683
Endoscopic manometry of the sphincter of Oddi and pancreatic duct in patients with chronic pancreatitis. 61
8807364 1996
684
Functional dyspepsia: how could a biliary dyspepsia sub-group be recognized? A methodological approach. 61
8842844 1996
685
[Endoscopic manometry in suspected dysfunction of the sphincter of Oddi]. 61
8612461 1996
686
Chronic acalculous cholecystitis: laparoscopic treatment. 61
8680633 1996
687
[Sphincter of Oddi dysfunction]. 61
8707223 1996
688
The efficacy of endoscopic sphincterotomy in patients with sphincter of Oddi dysfunction. 61
8935223 1996
689
Do patients with sphincter of Oddi dysfunction benefit from endoscopic sphincterotomy? A 5-year prospective trial. 61
8724026 1996
690
Sphincter of Oddi. 61
8689145 1996
691
Long-term clinical outcome of post-cholecystectomy patients with biliary-type pain: results of manometry, non-invasive techniques and endoscopic sphincterotomy. 61
8724025 1996
692
Is intervention necessary after a first episode of acute idiopathic pancreatitis? 61
8801214 1996
693
Defining sphincter of oddi dysfunction. 61
8903565 1996
694
Therapy of sphincter of Oddi dysfunction. 61
8903566 1996
695
[The role of different investigations in diagnosis of functional disorders of the biliary system]. 61
9121086 1996
696
[Biliary dyskinesia, sphincter of Oddi dysfunction]. 61
8705445 1996
697
Biopsies of the ampullary region in patients suspected to have sphincter of Oddi dysfunction. 61
8536895 1995
698
[Dynamics of biliary prostaglandin secretion in patients with dyskinesia of the biliary tracts]. 61
8700594 1995
699
Long-term management of biliary tract complications. 61
9346600 1995
700
Ampulla of Vater/duodenal wall spasm diagnosed by antroduodenal manometry. 61
7648970 1995
701
[Management of hypertensive dyskinesia of Oddi's sphincter. Correlation between the frequency of complications from endoscopic sphincterotomy and the diameter of the common bile duct]. 61
7637986 1995
702
Abnormal sphincter of Oddi response to cholecystokinin in postcholecystectomy syndrome patients with irritable bowel syndrome. The irritable sphincter. 61
7729279 1995
703
Success and yield of second attempt ERCP. 61
7615221 1995
704
Common bile duct sphincter of Oddi stenting in patients with suspected sphincter dysfunction. 61
7717316 1995
705
[Gallbladder motility following intake of mineral bicarbonate-alkaline water. Ultrasonographic assessment]. 61
7603608 1995
706
[20 years of endoscopic papillotomy. Analysis of 2752 patients at Erlangen Hospital]. 61
7851286 1995
707
Experience with a catheter-based ultrasound probe in the bile duct and pancreas. 61
7601051 1995
708
Sphincter of Oddi dysfunction after liver transplantation. 61
7821122 1995
709
Sphincter of Oddi dysfunction caused by an ampullary neoplasm. 61
7806047 1995
710
Biliary manometry in swine: a unique endoscopic model for teaching and research. 61
7601040 1995
711
Major hemorrhage from endoscopic sphincterotomy: risk factor analysis. 61
7876506 1994
712
[Diagnostic and therapeutic possibilities in suspected Oddi's sphincter dysfunction]. 61
7871862 1994
713
Efficacy of quantitative cholescintigraphy in the diagnosis of sphincter of Oddi dysfunction. 61
7870397 1994
714
Laparoscopic cholecystectomy in a freestanding outpatient surgery center. 61
7833511 1994
715
Intestinal dysmotility in patients with sphincter of Oddi dysfunction. A reason for failed response to sphincterotomy. 61
8082501 1994
716
Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction. 61
7959245 1994
717
Gallbladder ejection fraction. Nondiagnostic for sphincter of Oddi dysfunction in patients with intact gallbladders. 61
7955753 1994
718
The role of ERCP in the diagnosis and treatment of idiopathic recurrent pancreatitis in children and adolescents. 61
7926532 1994
719
[Delayed (modified) oral cholecystography in the study of biliary dyskinesia]. 61
7748104 1994
720
Estrogen inhibits sphincter of Oddi motility. 61
8041152 1994
721
Oddi: the paradox of the man and the sphincter. 61
8185478 1994
722
Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. 61
8122639 1994
723
Differentiation between organic stenosis and functional dyskinesia of the sphincter of Oddi with amyl nitrite-augmented quantitative hepatobiliary scintigraphy. 61
7911082 1994
724
Long-term outcome after endoscopic sphincterotomy in patients with biliary colic and suspected sphincter of Oddi dysfunction. 61
8013815 1994
725
Sphincter of Oddi dysfunction following liver transplantation. Screening by bedside manometry and definitive manometric evaluation. 61
8313805 1994
726
Gallbladder ejection fraction and its relationship to sphincter of Oddi dysfunction. 61
8313810 1994
727
Dynamic endoscopic manometry of the response to secretin in patients with chronic pancreatitis. 61
8026369 1994
728
Pathophysiology of the sphincter of Oddi. 61
8248840 1993
729
Post-cholecystectomy patients with "objective signs" of partial bile outflow obstruction: clinical characteristics, sphincter of Oddi manometry findings, and results of therapy. 61
8293900 1993
730
Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. 61
8224687 1993
731
Sphincter of Oddi dysfunction in patients with intact gallbladder: therapeutic response to endoscopic sphincterotomy. 61
8365594 1993
732
The incidence of post-sphincterotomy stenosis in group II patients with sphincter of Oddi dysfunction. 61
8365595 1993
733
A correlation between carotenemia and biliary dyskinesia. 61
8340533 1993
734
Human sphincter of Oddi motility and cholecystokinin response following liver transplantation. 61
8444077 1993
735
Familial acalculous gallbladder disease. 61
8434290 1993
736
[The clinical picture, diagnosis and treatment of thoracalgias]. 61
8191746 1993
737
[The role of biliary dyskinesia in the mechanism of the damage to the protective properties of the mucosal barrier in peptic ulcer]. 61
9133010 1993
738
What is behind dyspepsia? 61
8420748 1993
739
[Gallbladder dyskinesia and manometry of Oddi's sphincter]. 61
8211046 1993
740
Status evaluation: sphincter of Oddi manometry. American Society for Gastrointestinal Endoscopy. Technology Assessment Committee. 61
1473701 1992
741
Delayed biliary drainage is common in asymptomatic post-cholecystectomy volunteers. 61
1511817 1992
742
Correlation of basal sphincter pressures measured from the bile duct and the pancreatic duct in patients with suspected sphincter of Oddi dysfunction. 61
1511818 1992
743
[The correction of functional disorders of the bile-secreting system by using laser radiation]. 61
1455793 1992
744
[Effects of fenoverine on biliary kinetics evaluated by hepatobiliary scintigraphy with 99mTc-Br-IDA]. 61
1630696 1992
745
The scintigraphic evaluation of sphincter of Oddi dysfunction. 61
1597743 1992
746
A noninvasive test of sphincter of Oddi dysfunction in postcholecystectomy patients: the scintigraphic score. 61
1597742 1992
747
[The importance of crystallography for the diagnosis of biliary dyskinesia]. 61
1455814 1992
748
Efficacy of nifedipine therapy in patients with sphincter of Oddi dysfunction: a prospective, double-blind, randomized, placebo-controlled, cross over trial. 61
1524959 1992
749
Incidence and risk factors for biliary and pancreatic stent migration. 61